Profile image of Michael Berk

Prof Michael Berk

STAFF PROFILE

Position

Alfred Deakin Professor

Faculty

Faculty of Health

Department

School of Medicine

Campus

Barwon Health

Publications

Filter by

2018

The limitations of using randomised controlled trials as a basis for developing treatment guidelines

R Mulder, A Singh, A Hamilton, P Das, T Outhred, G Morris, D Bassett, B Baune, M Berk, P Boyce, B Lyndon, G Parker, G Malhi

(2018), Vol. 21, pp. 4-6, Evidence-based mental health, London, Eng., C1

journal

Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome

S Kim, H Kang, K Bae, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon, J Kim

(2018), Vol. 80, pp. 250-254, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1

journal

Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.

Aswin Ratheesh, Susan Cotton, Christopher Davey, Ashleigh Lin, Stephen Wood, Hok Yuen, Andreas Bechdolf, Patrick McGorry, Alison Yung, Michael Berk, Barnaby Nelson

(2018), Vol. 192, pp. 345-350, Schizophr Res, Netherlands, C1-1

journal

The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases.

Gerwyn Morris, Ken Walder, André Carvalho, Susannah Tye, Kurt Lucas, Michael Berk, Michael Maes

(2018), Vol. 84, pp. 453-469, Neurosci Biobehav Rev, United States, C1

journal

Cognition in depression: Can we THINC-it better?

Bernhard Baune, Gin Malhi, Grace Morris, Tim Outhred, Amber Hamilton, Pritha Das, Darryl Bassett, Michael Berk, Philip Boyce, Bill Lyndon, Roger Mulder, Gordon Parker, Ajeet Singh

(2018), Vol. 225, pp. 559-562, J Affect Disord, Netherlands, C1

journal

Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults.

Mohammadreza Mohebbi, Van Nguyen, John McNeil, Robyn Woods, Mark Nelson, Raj Shah, Elsdon Storey, Anne Murray, Christopher Reid, Brenda Kirpach, Rory Wolfe, Jessica Lockery, Michael Berk, ASPREE Investigator Group

(2018), Vol. 51, pp. 118-125, Gen Hosp Psychiatry, United States, C1

journal

A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression.

Chutima Roomruangwong, George Anderson, Michael Berk, Drozdstoy Stoyanov, André Carvalho, Michael Maes

(2018), Vol. 81, pp. 262-274, Prog Neuropsychopharmacol Biol Psychiatry, England, C1

journal

Post-Operative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies.

David Skvarc, Michael Berk, Linda Byrne, Olivia Dean, Seetal Dodd, Matthew Lewis, Andrew Marriott, Eileen Moore, Gerwyn Morris, Richard Page, Laura Gray

(2018), Vol. 84, pp. 116-133, Neurosci Biobehav Rev, United States, C1

journal

Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking.

Nieves Gómez-Coronado, Adam Walker, Michael Berk, Seetal Dodd

(2018), Vol. 38, pp. 235-258, Pharmacotherapy, United States, C1

journal

Bipolar disorders.

Eduard Vieta, Michael Berk, Thomas Schulze, André Carvalho, Trisha Suppes, Joseph Calabrese, Keming Gao, Kamilla Miskowiak, Iria Grande

(2018), Vol. 4, pp. 18008-, Nat Rev Dis Primers, England, C1

journal

Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders.

Taeyoung Yoo, Wonsuk Choi, Jin-Hee Hong, Ju-Yeon Lee, Jae-Min Kim, Il-Seon Shin, Soo Yang, Paul Amminger, Michael Berk, Jin-Sang Yoon, Sung-Wan Kim

(2018), Psychiatry Investig, Korea (South), C1

journal

Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania.

Orwa Dandash, Murat Yücel, Rothanthi Daglas, Christos Pantelis, Patrick McGorry, Michael Berk, Alex Fornito

(2018), Vol. 8, pp. 59-, Transl Psychiatry, United States, C1

journal

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Lakshmi Yatham, Sidney Kennedy, Sagar Parikh, Ayal Schaffer, David Bond, Benicio Frey, Verinder Sharma, Benjamin Goldstein, Soham Rej, Serge Beaulieu, Martin Alda, Glenda MacQueen, Roumen Milev, Arun Ravindran, Claire O'Donovan, Diane McIntosh, Raymond Lam, Gustavo Vazquez, Flavio Kapczinski, Roger McIntyre, Jan Kozicky, Shigenobu Kanba, Beny Lafer, Trisha Suppes, Joseph Calabrese, Eduard Vieta, Gin Malhi, Robert Post, Michael Berk

(2018), Vol. 20, pp. 97-170, Bipolar Disord, Denmark, C1

journal
2017

Ethical considerations in preventive interventions for bipolar disorder.

A Ratheesh, S Cotton, C Davey, S Adams, A Bechdolf, C Macneil, M Berk, P McGorry

(2017), Vol. 11, pp. 104-112, Early intervention in psychiatry, Milton, Queensland, C1

journal

A potential role for N-acetylcysteine in the management of methamphetamine dependence

R McKetin, O Dean, A Baker, G Carter, A Turner, P Kelly, M Berk

(2017), Vol. 36, pp. 153-159, Drug and alcohol review, London, Eng., C1

journal

The prevalence, age distribution and comorbidity of personality disorders in Australian women

S Quirk, M Berk, J Pasco, S Brennan-Olsen, A Chanen, H Koivumaa-Honkanen, L Burke, H Jackson, C Hulbert, C Olsson, P Moran, A Stuart, L Williams

(2017), Vol. 51, pp. 141-150, Australia and New Zealand journal of psychiatry, Melbourne, Vic., C1

journal

A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder

O Dean, K Gray, K-A Villagonzalo, S Dodd, M Mohebbi, T Vick, B Tonge, M Berk

(2017), Vol. 51, pp. 241-249, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: new pathways in neuroprogressive disorders Including depression and chronic fatigue syndrome.

G Morris, M Berk, H Klein, K Walder, P Galecki, M Maes

(2017), Vol. 54, pp. 4271-4291, Molecular neurobiology, Berlin, Germany, C1

journal

Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology

J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean

(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1

journal

Do sleep disturbances predict or moderate the response to psychotherapy in bipolar disorder?

L Sylvia, S Salcedo, A Peters, P Magalhães, E Frank, D Miklowitz, M Otto, M Berk, A Nierenberg, T Deckersbach

(2017), Vol. 205, pp. 196-202, Journal of nervous and mental disease, Philadelphia, Pa., C1

journal

Predictors for clinical deterioration of mental state in patients assessed by telephone-based mental health triage

N Sands, S Elsom, R Corbett, S Keppich-Arnold, R Prematunga, M Berk, J Considine

(2017), Vol. 26, pp. 226-237, International journal of mental health nursing, Milton, Qld., C1

journal

Why so GLUMM? Detecting depression clusters through graphing lifestyle-environs using machine-learning methods (GLUMM)

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), Vol. 39, pp. 40-50, European psychiatry, Amsterdam, The Netherlands, C1

journal

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study

C Bousman, D Müller, C Ng, K Byron, M Berk, A Singh

(2017), Vol. 27, pp. 1-6, Pharmacogenetics and genomics, London, Eng., C1

journal

Hierarchical estimation of neural activity through explicit identification of temporally synchronous spikes

R Veerabhadrappa, A Bhatti, M Berk, S Tye, S Nahavandi

(2017), Vol. 249, pp. 299-313, Neurocomputing, Amsterdam, The Netherlands, C1

journal

Cognitive effects of adjunctive N-acetyl cysteine in psychosis

M Rapado-Castro, S Dodd, A Bush, G Malhi, D Skvarc, Z On, M Berk, O Dean

(2017), Vol. 47, pp. 866-876, Psychological medicine, Cambridge, Eng., C1

journal

Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: evidence for defective immunomodulatory mechanisms

S de Campos-Carli, M Araújo, A de Oliveira Silveira, V de Rezende, N Rocha, R Ferretjans, R Ribeiro-Santos, A Teixeira-Carvalho, O Martins-Filho, M Berk, J Salgado, A Teixeira

(2017), Vol. 87, pp. 44-52, Journal of psychiatric research, Amsterdam, The Netherlands, C1

journal

A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder

A Ratheesh, C Davey, S Hetrick, M Alvarez-Jimenez, C Voutier, A Bechdolf, P McGorry, J Scott, M Berk, S Cotton

(2017), Vol. 135, pp. 273-284, Acta psychiatrica Scandinavica, London, Eng., C1

journal

A model of the mitochondrial basis of bipolar disorder

G Morris, K Walder, S McGee, O Dean, S Tye, M Maes, M Berk

(2017), Vol. 74, pp. 1-20, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Towards recovery-oriented psychosocial interventions for bipolar disorder: quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms

G Murray, N Leitan, N Thomas, E Michalak, S Johnson, S Jones, T Perich, L Berk, M Berk

(2017), Vol. 52, pp. 148-163, Clinical psychology review, Amsterdam, The Netherlands, C1

journal

Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume

M Berk, O Dandash, R Daglas, S Cotton, K Allott, A Fornito, C Suo, P Klauser, B Liberg, L Henry, C Macneil, M Hasty, P McGorry, C Pantelis, M Yücel

(2017), Vol. 7, pp. 1-7, Translational psychiatry, London, Eng., C1

journal

A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)

F Jacka, A O'Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, S Dash, C Mihalopoulos, M Chatterton, L Brazionis, O Dean, A Hodge, M Berk

(2017), Vol. 15, pp. 1-13, BMC medicine, London, Eng., C1

journal

A review of the theoretical and biological understanding of the nocebo and placebo phenomena

S Dodd, O Dean, J Vian, M Berk

(2017), Vol. 39, pp. 469-476, Clinical therapeutics, Amsterdam, The Netherlands, C1

journal

Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools

C Bousman, M Forbes, M Jayaram, H Eyre, C Reynolds, M Berk, M Hopwood, C Ng

(2017), Vol. 17, pp. 1-7, BMC psychiatry, London, Eng., C1

journal

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

J Firth, B Stubbs, J Sarris, S Rosenbaum, S Teasdale, M Berk, A Yung

(2017), Vol. 47, pp. 1515-1527, Psychological medicine, Cambridge, Eng., C1

journal

Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis

M Chatterton, E Stockings, M Berk, J Barendregt, R Carter, C Mihalopoulos

(2017), Vol. 210, pp. 333-341, British journal of psychiatry, London, Eng., C1

journal

The placebo and nocebo phenomena: their clinical management and impact on treatment outcomes

V Chavarria, J Vian, C Pereira, J Data-Franco, B Fernandes, M Berk, S Dodd

(2017), Vol. 39, pp. 477-486, Clinical therapeutics, New York, N.Y., C1

journal

Association between bipolar spectrum disorder and bone health: a meta-analysis and systematic review protocol

V Chandrasekaran, S Brennan-Olsen, A Stuart, J Pasco, M Berk, J Hodge, L Williams

(2017), Vol. 7, pp. 1-4, BMJ open, London, Eng., C1

journal

Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial

M Berk, R Daglas, O Dandash, M Yücel, L Henry, K Hallam, C Macneil, M Hasty, C Pantelis, B Murphy, L Kader, S Damodaran, M Wong, P Conus, A Ratheesh, P McGorry, S Cotton

(2017), Vol. 210, pp. 413-421, British journal of psychiatry, London, United Kingdom, C1

journal

Progressing MoodSwings. The upgrade and evaluation of MoodSwings 2.0: an online intervention for bipolar disorder

S Lauder, V Cosgrove, E Gliddon, D Grimm, S Dodd, L Berk, D Castle, T Suppes, M Berk

(2017), Vol. 56, pp. 18-24, Contemporary clinical trials, Amsterdam, The Netherlands, C1

journal

Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean

(2017), pp. 1-10, Acta neuropsychiatrica, Cambridge, Eng., C1

journal

Do statins have antidepressant effects?

O Köhler-Forsberg, C Gasse, M Berk, S Østergaard

(2017), Vol. 31, pp. 335-343, CNS drugs, Cham, Switzerland, C1

journal

Homocysteine as a peripheral biomarker in bipolar disorder: a meta-analysis

E Salagre, A Vizuete, M Leite, D Brownstein, A McGuinness, F Jacka, S Dodd, B Stubbs, C Köhler, E Vieta, A Carvalho, M Berk, B Fernandes

(2017), Vol. 43, pp. 81-91, European psychiatry, Amsterdam, The Netherlands, C1

journal

The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - Cadence-BZ: study protocol for a randomized controlled trial

A Ryan, A Baker, F Dark, S Foley, A Gordon, S Hatherill, S Stathis, S Saha, G Bruxner, M Beckman, D Richardson, M Berk, O Dean, J McGrath, Cadence Working Group, J Scott

(2017), Vol. 18, pp. 1-11, Trials, London, Eng., C1

journal

Youth self-harm in low- and middle-income countries: systematic review of the risk and protective factors

S Aggarwal, G Patton, N Reavley, S Sreenivasan, M Berk

(2017), Vol. 63, pp. 359-375, International journal of social psychiatry, London, Eng., C1

journal

the effect of n-acetylcysteine (nac) on human cognition - a systematic review

D Skvarc, O Dean, L Byrne, L Gray, S Lane, M Lewis, B Fernandes, M Berk, A Marriott

(2017), Vol. 78, pp. 44-56, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal

Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder

L Berk, K Hallam, K Venugopal, A Lewis, D Austin, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, M Berk

(2017), Vol. 19, pp. 184-197, Bipolar disorders, Hoboken, N.J., C1

journal

Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses

B Bortolato, C Köhler, E Evangelou, J León-Caballero, M Solmi, B Stubbs, L Belbasis, I Pacchiarotti, L Kessing, M Berk, E Vieta, A Carvalho

(2017), Vol. 19, pp. 84-96, Bipolar disorders, London, Eng., C1

journal

Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients

G Scaini, G Fries, S Valvassori, C Zeni, G Zunta-Soares, M Berk, J Soares, J Quevedo

(2017), Vol. 7, pp. 1-10, Translational psychiatry, [New York, N.Y.], C1

journal

Evaluation of modified patient health questionnaire-9 teen in South African adolescents

S Aggarwal, L Taljard, Z Wilson, M Berk

(2017), Vol. 39, pp. 143-145, Indian Journal of Psychological Medicine, Mumbai, India, C1

journal

Association between bipolar spectrum disorder and bone health: a meta-analysis and systematic review protocol

Vinoomika Chandrasekaran, Sharon Brennan-Olsen, Amanda Stuart, Julie Pasco, Michael Berk, Jason Hodge, Lana Williams

(2017), Vol. 7, BMJ OPEN, C1

journal

Pattern of psychotropic medication use over two decades in Australian women

A Stuart, M Mohebbi, J Pasco, S Quirk, S Brennan-Olsen, M Berk, L Williams

(2017), pp. 1-8, Australian and New Zealand Journal of Psychiatry, London, Eng., C1

journal

A comparison of neuroimaging abnormalities in multiple sclerosis, major depression and chronic fatigue syndrome (myalgic encephalomyelitis): is there a common cause?

G Morris, M Berk, B Puri

(2017), pp. 1-18, Molecular neurobiology, Cham, Switzerland, C1

journal

Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial

O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk

(2017), Vol. 51, pp. 829-840, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Social and academic premorbid adjustment domains predict different functional outcomes among youth with first episode mania

A Ratheesh, C Davey, R Daglas, C Macneil, M Hasty, K Filia, P McGorry, M Berk, P Conus, S Cotton

(2017), Vol. 219, pp. 133-140, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Defining melancholia: a core mood disorder

G Parker, D Bassett, T Outhred, G Morris, A Hamilton, P Das, B Baune, M Berk, P Boyce, B Lyndon, R Mulder, A Singh, G Malhi

(2017), Vol. 19, pp. 235-237, Bipolar disorders, London, Eng., C1

journal

Psychotropic pharmacogenetics - distraction or destiny?

A Singh, B Baune, A Hamilton, P Das, T Outhred, G Morris, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, G Malhi

(2017), Vol. 51, pp. 665-667, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

International multi-site survey on the use of online support groups in bipolar disorder

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Zompo, R Dias, S Dodd, A Duffy, B Etain

(2017), Vol. 71, pp. 473-476, Nordic Journal of Psychiatry, Abingdon, Eng, C1

journal

Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers

K Landucci Bonifácio, D Sabbatini Barbosa, E Gastaldello Moreira, C de Farias, L Higachi, A Camargo, J Favaro Soares, H Odebrecht Vargas, S Nunes, M Berk, S Dodd, M Maes

(2017), Vol. 222, pp. 185-194, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Solar insolation in springtime influences age of onset of bipolar I disorder

M Bauer, T Glenn, M Alda, M Aleksandrovich, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, S Bharathram, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, ? Bicakci, H Birabwa-Oketcho, T Bjella, S Dodd

(2017), pp. 1-12, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1

journal

Mixed mood: the not so united states?

G Malhi, M Berk, G Morris, A Hamilton, T Outhred, P Das, D Bassett, B Baune, P Boyce, B Lyndon, R Mulder, G Parker, A Singh

(2017), Vol. 19, pp. 242-245, Bipolar Disorders, Hoboken, N. J., C1

journal

Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials

D Brownstein, E Salagre, C Köhler, B Stubbs, J Vian, C Pereira, V Chavarria, C Karmakar, A Turner, J Quevedo, A Carvalho, M Berk, B Fernandes

(2017), pp. 1-16, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

The renin-angiotensin system: a possible new target for depression

J Vian, C Pereira, V Chavarria, C Köhler, B Stubbs, J Quevedo, S-W Kim, A Carvalho, M Berk, B Fernandes

(2017), Vol. 15, pp. 144-156, BMC Medicine, London, Eng., C1

journal

Online ethics: where will the interface of mental health and the internet lead us?

V Cosgrove, E Gliddon, L Berk, D Grimm, S Lauder, S Dodd, M Berk, T Suppes

(2017), Vol. 5, pp. 1-9, International journal of bipolar disorders, London, Eng., C1

journal

Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder.

Izabela Barbosa, Gabriela Vaz, Natalia Rocha, Rodrigo Machado-Vieira, Marcio Ventura, Rodrigo Huguet, Moises Bauer, Michael Berk, Antônio Teixeira

(2017), Vol. 15, pp. 269-275, Clin Psychopharmacol Neurosci, Korea (South), C1

journal

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.

M Berger, S Smesny, S-W Kim, C Davey, S Rice, Z Sarnyai, M Schlögelhofer, M Schäfer, M Berk, P McGorry, G Amminger

(2017), Vol. 7, pp. e1220-, Transl Psychiatry, United States, C1

journal

Getting RID of the blues: formulating a Risk Index for Depression (RID) using structural equation modeling

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), pp. 1-13, Australian & New Zealand Journal of Psychiatry, London, Eng., C1

journal

Personality disorder is an excess risk factor for physical multimorbidity among women with mental state disorders

S Quirk, A Stuart, M Berk, J Pasco, S Brennan Olsen, H Koivumaa-Honkanen, R Honkanen, P Lukkala, A Chanen, M Kotowicz, L Williams

(2017), Vol. 257, pp. 546-549, Psychiatry Research, Shannon, Clare Ireland, C1

journal

N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis.

Michel Duailibi, Quirino Cordeiro, Elisa Brietzke, Marcelo Ribeiro, Steve LaRowe, Michael Berk, Alisson Trevizol

(2017), Vol. 26, pp. 660-666, Am J Addict, England, C1

journal

Staging in bipolar disorder: from theoretical framework to clinical utility

M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd

(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1

journal

Nutritional psychiatry: the present state of the evidence.

Wolfgang Marx, Genevieve Moseley, Michael Berk, Felice Jacka

(2017), Vol. 76, pp. 427-436, Proc Nutr Soc, England, C1

journal

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.

Seetal Dodd, Philip Mitchell, Michael Bauer, Lakshmi Yatham, Allan Young, Sidney Kennedy, Lana Williams, Trisha Suppes, Carlos Lopez Jaramillo, Madhukar Trivedi, Maurizio Fava, A Rush, Roger McIntyre, Michael Thase, Raymond Lam, Emanuel Severus, Siegfried Kasper, Michael Berk

(2017), pp. 1-19, World J Biol Psychiatry, England, C1

journal

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.

G Morris, A Walker, M Berk, M Maes, B Puri

(2017), Mol Neurobiol, United States, C1

journal

Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat

I Oberholzer, M Möller, B Holland, O Dean, M Berk, B Harvey

(2017), pp. 1-14, Metabolic brain disease, New York, N.Y., C1

journal

The role of depression pharmacogenetic decision support tools in shared decision making.

Katarina Arandjelovic, Harris Eyre, Eric Lenze, Ajeet Singh, Michael Berk, Chad Bousman

(2017), J Neural Transm (Vienna), Austria, C1

journal

Distinguishing transient versus stable aspects of depression in New Zealand Pacific Island children using Generalizability Theory

J Paterson, O Medvedev, A Sumich, E Tautolo, C Krägeloh, R Sisk, R McNamara, M Berk, A Narayanan, R Siegert

(2017), Vol. 227, pp. 698-704, Journal of Affective Disorders, C1

journal

Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Joseph Firth, Rebekah Carney, Brendon Stubbs, Scott Teasdale, Davy Vancampfort, Philip Ward, Michael Berk, Jerome Sarris

(2017), Schizophr Bull, United States, C1

journal

Cognitive functioning following stabilisation from first episode mania.

Rothanthi Daglas, Kelly Allott, Murat Yücel, Lisa Henry, Craig Macneil, Melissa Hasty, Michael Berk, Sue Cotton

(2017), Vol. 5, pp. 39-, Int J Bipolar Disord, Germany, C1

journal

Mitochondrial modifying nutrients in treating chronic fatigue syndrome: A 16-week open-label pilot study

R Menon, L Cribb, J Murphy, M Ashton, G Oliver, N Dowling, A Turner, O Dean, M Berk, C Ng, J Sarris

(2017), Vol. 4, pp. 109-114, Advances in Integrative Medicine, C1

journal
2016

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial

S Rice, I Hickie, A Yung, A Mackinnon, M Berk, C Davey, D Hermens, S Hetrick, A Parker, M Schäfer, P McGorry, G Amminger

(2016), Vol. 10, pp. 290-299, Early Intervention in Psychiatry, London, Eng., C1

journal

The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases

G Morris, M Berk, P Galecki, K Walder, M Maes

(2016), Vol. 53, pp. 1195-1219, Molecular neurobiology, Berlin, Germany, C1

journal

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonçalves, M Berk

(2016), Vol. 21, pp. 554-564, Molecular psychiatry, London, Eng., C1

journal

The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling : new drug targets in neuroimmune disorders

G Morris, K Walder, B Puri, M Berk, M Maes

(2016), Vol. 53, pp. 4638-4658, Molecular neurobiology, New York, N.Y., C1

journal

Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways

M Martin-Subero, G Anderson, B Kanchanatawan, M Berk, M Maes

(2016), Vol. 21, pp. 184-198, CNS Spectrums, Cambridge, Eng., C1

journal

Bipolar disorder

I Grande, M Berk, B Birmaher, E Vieta

(2016), Vol. 387, pp. 1561-1572, Lancet, Amsterdam, The Netherlands, C1

journal

Autobiographical memory dysfunctions in depressive disorders

M Talarowska, M Berk, M Maes, P Ga?ecki

(2016), Vol. 70, pp. 100-108, Psychiatry and clinical neurosciences, London, Eng., C1

journal

The prevalence and age of onset of psychiatric disorders in Australian men

L Williams, F Jacka, J Pasco, C Coulson, S Quirk, A Stuart, M Berk

(2016), Vol. 50, pp. 678-684, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Effects of depression and serotonergic antidepressants on bone: Mechanisms and implications for the treatment of depression

B Fernandes, J Hodge, J Pasco, M Berk, L Williams

(2016), Vol. 33, pp. 21-25, Drugs & aging, Berlin, Germany, C1

journal

Theory of mind in major depressive disorder: a meta-analysis

E Bora, M Berk

(2016), Vol. 191, pp. 49-55, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study

R Daglas, S Cotton, K Allott, M Yücel, C Macneil, M Hasty, B Murphy, C Pantelis, K Hallam, L Henry, P Conus, A Ratheesh, L Kader, M Wong, P McGorry, M Berk

(2016), Vol. 31, pp. 20-28, European psychiatry, Amsterdam, The Netherlands, C1

journal

The trajectory of cognitive functioning following first episode mania: a 12-month follow-up study

R Daglas, K Allott, M Yücel, C Pantelis, C Macneil, M Berk, S Cotton

(2016), Vol. 50, pp. 1186-1197, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Depression as a risk factor for fracture in women: a 10 year longitudinal study

L Williams, J Pasco, H Jackson, L Kiropoulos, A Stuart, F Jacka, M Berk

(2016), Vol. 192, pp. 34-40, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

DNA methylation and the social gradient of osteoporotic fracture: a conceptual model

S Brennan-Olsen, R Page, M Berk, J Riancho, W Leslie, S Wilson, K Saban, L Janusek, J Pasco, J Hodge, S Quirk, N Hyde, S Hosking, L Williams

(2016), Vol. 84, pp. 204-212, Bone, Amsterdam, The Netherlands, C1

journal

Regulators of mitochondrial complex I activity: a review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder

A Duong, Y Che, D Ceylan, A Pinguelo, A Andreazza, L Trevor Young, M Berk

(2016), Vol. 236, pp. 148-157, Psychiatry research, Amsterdam, The Netherlands, C1

journal

Population prevalence of personality disorder and associations with physical health comorbidities and health care service utilization: a review

S Quirk, M Berk, A Chanen, H Koivumaa-Honkanen, S Brennan-Olsen, J Pasco, L Williams

(2016), Vol. 7, pp. 136-146, Personality disorders, Washington, D.C., C1

journal

Specific mood symptoms confer risk for subsequent suicidal ideation in bipolar disorder with and without suicide attempt history: multi-wave data from STEP-BD

J Stange, E Kleiman, L Sylvia, P Magalhães, M Berk, A Nierenberg, T Deckersbach

(2016), Vol. 33, pp. 464-472, Depression and anxiety, London, Eng., C1

journal

Cognitive remission: a novel objective for the treatment of major depression?

B Bortolato, K Miskowiak, C Köhler, M Maes, B Fernandes, M Berk, A Carvalho

(2016), Vol. 14, pp. 1-18, BMC medicine, London, Eng., C1

journal

Bias in peripheral depression biomarkers

A Carvalho, C Köhler, A Brunoni, K Miskowiak, N Herrmann, K Lanctôt, T Hyphantis, J Quevedo, B Fernandes, M Berk

(2016), Vol. 85, pp. 81-90, Psychotherapy and psychosomatics, Basel, Switzerland, C1

journal

Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment

J Stange, L Sylvia, P da Silva Magalhães, D Miklowitz, M Otto, E Frank, C Yim, M Berk, D Dougherty, A Nierenberg, T Deckersbach

(2016), Vol. 208, pp. 352-358, British journal of psychiatry, London, Eng., C1

journal

Statin and aspirin use and the risk of mood disorders among men

L Williams, J Pasco, M Mohebbi, F Jacka, A Stuart, K Venugopal, A O'Neil, M Berk

(2016), Vol. 19, pp. 1-4, International journal of neuropsychopharmacology, Oxford, Eng., C1

journal

Harnessing the potential of community-based participatory research approaches in bipolar disorder

E Michalak, S Jones, F Lobban, G Algorta, S Barnes, L Berk, M Berk, R Hole, S Lapsley, V Maxwell, R Milev, J McManamy, G Murray, M Tohen, S Tse, M Sanchez de Carmona, S Johnson

(2016), Vol. 4, pp. 1-9, International journal of bipolar disorders, Berlin, Germany, C1

journal

Fusing data mining, machine learning and traditional statistics to detect biomarkers associated with depression

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, pp. 1-23, PLoS One, San Francisco, Calif., C1

journal

Niacin skin sensitivity is increased in adolescents at ultra-high risk for psychosis

G Berger, S Smesny, M Schäfer, B Milleit, K Langbein, U-C Hipler, C Milleit, C Klier, M Schlögelhofer, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Amminger

(2016), Vol. 11, pp. 1-17, PLoS one, San Francisco, Calif., C1

journal

Trajectory and predictors of quality of life in first episode psychotic mania

M Oldis, G Murray, C Macneil, M Hasty, R Daglas, M Berk, P Conus, S Cotton

(2016), Vol. 195, pp. 148-155, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

T helper 17 cells may drive neuroprogression in major depressive disorder: proposal of an integrative model

A Slyepchenko, M Maes, C Köhler, G Anderson, J Quevedo, G Alves, M Berk, B Fernandes, A Carvalho

(2016), Vol. 64, pp. 83-100, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

The putative use of lithium in alzheimer's disease

G Morris, M Berk

(2016), Vol. 13, pp. 853-861, Current alzheimer research, Bussum, Netherlands, C1

journal

Depression is a risk factor for incident coronary heart disease in women: an 18-year longitudinal study

A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, C Taylor, J Pasco

(2016), Vol. 196, pp. 117-124, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The addition of depression to the Framingham Risk Equation model for predicting coronary heart disease risk in women

A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, J Atherton, C Taylor, J Pasco

(2016), Vol. 87, pp. 115-120, Preventive Medicine Reports, Amsterdam, The Netherlands, C1

journal

Physical health comorbidities in women with personality disorder: data from the Geelong osteoporosis study

S Quirk, A Stuart, S Brennan-Olsen, J Pasco, M Berk, A Chanen, H Koivumaa-Honkanen, M Kotowicz, P Lukkala, L Williams

(2016), Vol. 34, pp. 29-35, European psychiatry, Amsterdam, The Netherlands, C1

journal

Fibromyalgia and bipolar disorder: emerging epidemiological associations and shared pathophysiology

B Bortolato, M Berk, M Maes, R McIntyre, A Carvalho

(2016), Vol. 16, pp. 119-136, Current molecular medicine, The Netherlands, Amsterdam, C1

journal

Relationship between erythrocyte fatty acid composition and psychopathology in the Vienna omega-3 study

S-W Kim, M Jhon, J-M Kim, S Smesny, S Rice, M Berk, C Klier, P McGorry, M Schäfer, G Amminger

(2016), Vol. 11, pp. 1-12, PLoS one, San Francisco, Calif., C1

journal

Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis

J Rosenblat, R Kakar, M Berk, L Kessing, M Vinberg, B Baune, R Mansur, E Brietzke, B Goldstein, R McIntyre

(2016), Vol. 18, pp. 89-101, Bipolar disorders, London, Eng., C1

journal

Mental health for all Australians

M Berk

(2016), Vol. 50, pp. 301-302, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Leptin in bipolar disorder: a systematic review and meta-analysis

B Fernandes, S Dash, F Jacka, S Dodd, A Carvalho, C Köhler, J Steiner, M da Graça Cantarelli, P Nardin, C Gonçalves, M Berk

(2016), Vol. 35, pp. 1-7, European psychiatry, Amsterdam, The Netherlands, C1

journal

A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis

J Davis, H Eyre, F Jacka, S Dodd, O Dean, S McEwen, M Debnath, J McGrath, M Maes, P Amminger, P McGorry, C Pantelis, M Berk

(2016), Vol. 65, pp. 185-194, Neuroscience & biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Associations between DNA damage, DNA base excision repair gene variability and Alzheimer's disease risk

D Kwiatkowski, P Czarny, M Toma, N Jurkowska, A Sliwinska, J Drzewoski, A Bachurska, J Szemraj, M Maes, M Berk, K-P Su, P Galecki, T Sliwinski

(2016), Vol. 41, pp. 152-171, Dementia and geriatric cognitive disorders, Basel, Switzerland, C1

journal

Areas of controversy in neuroprogression in bipolar disorder.

I Passos, B Mwangi, E Vieta, M Berk, F Kapczinski

(2016), Vol. 134, pp. 91-103, Acta psychiatrica scandinavica, London, Eng., C1

journal

Adjunctive nutraceuticals for depression: a systematic review and meta-analyses

J Sarris, J Murphy, D Mischoulon, G Papakostas, M Fava, M Berk, C Ng

(2016), Vol. 173, pp. 575-587, American journal of psychiatry, Arlington, Va., C1

journal

Antioxidant treatments for schizophrenia

P Magalhães, O Dean, A Andreazza, M Berk, F Kapczinski

(2016), Vol. 2016, pp. 1-93, Cochrane database of systematic reviews, London, Eng., C1

journal

N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis

B Fernandes, O Dean, S Dodd, G Malhi, M Berk

(2016), Vol. 77, pp. 457-466, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

Integrating early intervention for borderline personality disorder and mood disorders

A Chanen, M Berk, K Thompson

(2016), Vol. 24, pp. 330-341, Harvard review of psychiatry, Philadelphia, Pa., C1

journal

Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials

E Salagre, B Fernandes, S Dodd, D Brownstein, M Berk

(2016), Vol. 200, pp. 235-242, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Mental health system development in Asia: does Australia have a role?

K Arandjelovic, H Eyre, M Forbes, R Bauer, S Aggarwal, A Singh, B Baune, I Everall, M Berk, C Ng

(2016), Vol. 50, pp. 834-841, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Bias in emerging biomarkers for bipolar disorder

A Carvalho, C Köhler, B Fernandes, J Quevedo, K Miskowiak, A Brunoni, R Machado-Vieira, M Maes, E Vieta, M Berk

(2016), Vol. 46, pp. 2287-2297, Psychological Medicine, Cambridge, England, C1

journal

Is there a nexus between mental and bone health?

L Williams, J Pasco, J Hodge, M Berk

(2016), Vol. 50, pp. 829-830, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: results from STEP-BD

T Deckersbach, A Peters, L Sylvia, A Gold, P Da Silva Magalhaes, D Henry, E Frank, M Otto, M Berk, D Dougherty, A Nierenberg, D Miklowitz

(2016), Vol. 203, pp. 152-157, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects

Y Kim, S McGee, J Czeczor, A Walker, R Kale, A Kouzani, K Walder, M Berk, S Tye

(2016), Vol. 6, pp. 1-7, Translational psychiatry, London, Eng., C1

journal

Unified selective sorting approach to analyse multi-electrode extracellular data

R Veerabhadrappa, C Lim, T Nguyen, M Berk, S Tye, P Monaghan, S Nahavandi, A Bhatti

(2016), Vol. 6, pp. 1-16, Scientific reports, London, Eng., C1

journal

The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmunue disease.

G Morris, M Berk, A Carvalho, J Caso, Y Sanz, K Walder, M Maes

(2016), pp. 1-20, Molecular neurobiology, Berlin, Germany, C1

journal

Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder

F Kay-Lambkin, L Thornton, J Lappin, T Hanstock, L Sylvia, F Jacka, A Baker, M Berk, P Mitchell, R Callister, N Rogers, S Webster, S Dennis, C Oldmeadow, A MacKinnon, C Doran, A Turner, S Hunt

(2016), Vol. 5, pp. 1-7, Systematic reviews, London, Eng., C1

journal

Internet use by patients with bipolar disorder: results from an international multisite survey

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Hernandez, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O'Donovan, Y Okamura, Y Osher, P Piotrowski, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, ÂM Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, P Whybrow, M Bauer

(2016), Vol. 242, pp. 388-394, Psychiatry research, Amsterdam, The Netherlands, C1

journal

Mitochondrial dysfunction in bipolar disorder: evidence, pathophysiology and translational implications

G Scaini, G Rezin, A Carvalho, E Streck, M Berk, J Quevedo

(2016), Vol. 68, pp. 694-713, Neuroscience & biobehavioral reviews, London, Eng., C1

journal

Predicting risk of suicide attempt using history of physical illnesses from electronic medical records

C Karmakar, W Luo, T Tran, M Berk, S Venkatesh

(2016), Vol. 3, pp. 1-10, JMIR mental health, Toronto, Ont., C1

journal

Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression

A Peters, L Shesler, L Sylvia, P Da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, D Dougherty, A Nierenberg, T Deckersbach

(2016), Vol. 50, pp. 667-677, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial

J Kulkarni, E Gavrilidis, S Gwini, R Worsley, J Grigg, A Warren, C Gurvich, H Gilbert, M Berk, S Davis

(2016), Vol. 73, pp. 947-954, JAMA psychiatry, Chicago, Ill., C1

journal

ASPREE-D: Aspirin for the prevention of depression in the elderly

M Berk, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, A Murray, B Kirpach, R Grimm, J McNeil

(2016), Vol. 28, pp. 1741-1748, International psychogeriatrics, Cambridge, Eng., C1

journal

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

D Skvarc, O Dean, L Byrne, L Gray, K Ives, S Lane, M Lewis, C Osborne, R Page, D Stupart, A Turner, M Berk, A Marriott

(2016), Vol. 17, pp. 1-11, Trials, London, Eng., C1

journal

Online information seeking by patients with bipolar disorder: results from an international multisite survey

J Conell, R Bauer, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Paredes Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, C Lam, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, P Piotrowski, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O'Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Â Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, I Zorrilla, P Whybrow, M Bauer

(2016), Vol. 4, pp. 1-14, International journal of bipolar disorders, London, Eng., C1

journal

The impact of HLA-G 3' UTR variants and sHLA-G on risk and clinical correlates of schizophrenia

A Rajasekaran, V Shivakumar, S Kalmady, J Narayanaswamy, M Subbana, D Venugopal, A Amaresha, G Venkatasubramanian, M Berk, M Debnath

(2016), Vol. 77, pp. 1166-1171, Human immunology, Amsterdam, The Netherlands, C1

journal

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

S Rossell, P Francis, C Galletly, A Harris, D Siskind, M Berk, K Bozaoglu, F Dark, O Dean, D Liu, D Meyer, E Neill, A Phillipou, J Sarris, D Castle

(2016), Vol. 16, pp. 1-9, BMC psychiatry, London, Eng., C1

journal

An ISBD perspective on the sociocultural challenges of managing bipolar disorder: a content analysis

C Oedegaard, L Berk, M Berk, E Youngstrom, S Dilsaver, R Belmaker, K Oedegaard, O Fasmer, I Engebretsen

(2016), Vol. 50, pp. 1096-1103, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Shortened telomere length in bipolar disorder: a comparison of the early and late stages of disease

F Barbé-Tuana, M Parisi, B Panizzutti, G Fries, L Grun, F Guma, F Kapczinski, M Berk, C Gama, A Rosa

(2016), Vol. 38, pp. 281-286, Revista brasileira de psiquiatria, Sao Paulo, Brazil, C1

journal

Immuno-psychiatry: an agenda for clinical practice and innovative research

M Leboyer, M Berk, R Yolken, R Tamouza, D Kupfer, L Groc

(2016), Vol. 14, pp. 1-8, BMC medicine, London, Eng., C1

journal

C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

B Fernandes, J Steiner, M Molendijk, S Dodd, P Nardin, C-A Gonçalves, F Jacka, C Köhler, C Karmakar, A Carvalho, M Berk

(2016), Vol. 3, pp. 1147-1156, Lancet psychiatry, Amsterdam, The Netherlands, C1

journal

Functional implications of the IL-23/IL-17 immune axis in schizophrenia

M Debnath, M Berk

(2016), pp. 1-9, Molecular neurobiology, Berlin, Germany, C1

journal

Single-nucleotide polymorphisms of genes involved in repair of oxidative DNA damage and the risk of recurrent depressive disorder

P Czarny, D Kwiatkowski, M Toma, P Ga?ecki, A Orzechowska, K Bobi?ska, A Bielecka-Kowalska, J Szemraj, M Berk, G Anderson, T ?liwi?ski

(2016), Vol. 22, pp. 4455-4474, Medical science monitor, Smithtown, N.Y., C1-1

journal

Guidelines for developing and reporting machine learning predictive models in biomedical research : a multidisciplinary view

W Luo, Q Phung, T Tran, S Gupta, S Rana, C Karmakar, A Shilton, J Yearwood, N Dimitrova, T Ho, S Venkatesh, M Berk

(2016), Vol. 18, pp. 1-10, Journal of medical internet research, Toronto, Ont., C1

journal

Into the bowels of depression: unravelling medical symptoms associated with depression by applying machine-learning techniques to a community based population sample

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, pp. 1-19, PLoS one, San Francisco, Calif., C1

journal

The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in alzheimer's disease

C Köhler, M Maes, A Slyepchenko, M Berk, M Solmi, K Lanctôt, A Carvalho

(2016), Vol. 22, pp. 6152-6166, Current pharmaceutical design, Bussum, Netherlands, C1

journal

Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes

A Slyepchenko, M Maes, R Machado-Vieira, G Anderson, M Solmi, Y Sanz, M Berk, C Köhler, A Carvalho

(2016), Vol. 22, pp. 6087-6106, Current pharmaceutical design, Bussum, The Netherlands, C1

journal

Gut permeability and microbiota in Parkinson's disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways

G Anderson, M Seo, M Berk, A Carvalho, M Maes

(2016), Vol. 22, pp. 6142-6151, Current pharmaceutical design, Bussum, The Netherlands, C1

journal

The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimmune processes with an emphasis on inflammatory bowel disease type 1 diabetes and chronic fatigue syndrome

G Morris, M Berk, A Carvalho, J Caso, Y Sanz, M Maes

(2016), Vol. 22, pp. 6058-6075, Current pharmaceutical design, Beijing, China, C1

journal

Electrical resistance increases at the tissue-electrode interface as an early response to nucleus accumbens deep brain stimulation

R Kale, A Kouzani, J Berk, K Walder, M Berk, S Tye

(2016), pp. 1814-1817, EMBC 2016 : Proceedings of the 38th Annual International Conference of the Engineering in Medicine and Biology Society, Orlando, Florida, E1

conference
2015

Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age

J Kulkarni, E Gavrilidis, Wang, W, R Worsley, P Fitzgerald, C Gurvich, T Van Rheenen, M Berk, H Burger

(2015), Vol. 20, pp. 695-702, Molecular psychiatry, Basingstoke, Eng., C1

journal

Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.

M Rapado-Castro, M Berk, K Venugopal, A Bush, S Dodd, O Dean

(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

journal

A randomized head to head trial of MoodSwings.net.au: an internet based self-help program for bipolar disorder

S Lauder, A Chester, D Castle, S Dodd, E Gliddon, L Berk, J Chamberlain, B Klein, M Gilbert, D Austin, M Berk

(2015), Vol. 171, pp. 13-21, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications

B Fernandes, J Steiner, M Berk, M Molendijk, A Gonzalez-Pinto, C Turck, P Nardin, C Gonçalves

(2015), Vol. 20, pp. 1108-1119, Molecular Psychiatry, London, Eng., C1

journal

The association between attributions of responsibility for motor vehicle accidents and patient satisfaction: a study within a no-fault injury compensation system

J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern

(2015), Vol. 29, pp. 500-508, Clinical rehabilitation, London, Eng., C1

journal

The relationships between insomnia, sleep apnoea and depression: findings from the American national health and nutrition examination survey, 2005-2008

A Hayley, L Williams, K Venugopal, G Kennedy, M Berk, J Pasco

(2015), Vol. 49, pp. 156-170, Australian & New Zealand journal of psychiatry, London, England, C1

journal

Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass

J Davis, M Maes, A Andreazza, J McGrath, S Tye, M Berk

(2015), Vol. 20, pp. 152-153, Molecular psychiatry, London, Eng., C1

journal

Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder

S Nunes, L Piccoli de Melo, M Pizzo de Castro, D Barbosa, H Vargas, M Berk, M Maes

(2015), Vol. 172, pp. 55-62, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the second Australian national psychosis survey

S Mancuso, V Morgan, P Mitchell, M Berk, A Young, D Castle

(2015), Vol. 172, pp. 30-37, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The gut microbiome and diet in psychiatry: focus on depression

S Dash, G Clarke, M Berk, F Jacka

(2015), Vol. 28, pp. 1-6, Current opinion in psychiatry, Philadelphia, Pa., C1

journal

Restless leg syndrome associated with atypical antipsychotics : current status, pathophysiology, and clinical implications

S Aggarwal, S Dodd, M Berk

(2015), Vol. 10, pp. 98-105, Current drug safety, San Francisco, Calif., C1-1

journal

Excessive daytime sleepiness and metabolic syndrome: a cross-sectional study

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2015), Vol. 64, pp. 244-252, Metabolism, Maryland Heights, MO, C1

journal

STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders.

M Pizzo de Castro, S Vargas Nunes, R Guembarovski, C Ariza, J Oda, H Vargas, L Piccoli de Melo, M Watanabe, M Berk, M Maes

(2015), Vol. 172, pp. 347-354, Journal of Affective Disorders, Amsterdam , Netherlands, C1

journal

Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications.

A Rajasekaran, G Venkatasubramanian, M Berk, M Debnath

(2015), Vol. 48, pp. 10-21, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal

Influence of birth cohort on age of onset cluster analysis in bipolar I disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Hatim Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 30, pp. 99-105, European psychiatry, Amsterdam, Netherlands, C1

journal

Evolution of adolescent mental health in a rapidly changing socioeconomic environment: a review of mental health studies in adolescents in India over last 10 years

S Aggarwal, M Berk

(2015), Vol. 13, pp. 3-12, Asian journal of psychiatry, Amsterdam, The Netherlands, C1

journal

Fetal programming of schizophrenia: select mechanisms

M Debnath, G Venkatasubramanian, M Berk

(2015), Vol. 49, pp. 90-104, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.

G Amminger, A Mechelli, S Rice, S Kim, C Klier, R McNamara, M Berk, P McGorry, M Schäfer

(2015), Vol. 5, pp. e495-e495, Translational Psychiatry, United States, C1

journal

The association between use of antidepressants and bone quality using quantitative heel ultrasound

P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams

(2015), Vol. 49, pp. 437-443, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

RF rectifiers for EM power harvesting in a deep brain stimulating device

M Hosain, A Kouzani, S Tye, A Kaynak, M Berk

(2015), Vol. 38, pp. 157-172, Australasian physical and engineering sciences in medicine, Berlin, Germany, C1

journal

Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis

M Berk, J Tiller, J Zhao, L Yatham, G Malhi, E Weiller

(2015), Vol. 76, pp. 728-734, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control.

A O'Neil, F Jacka, S Quirk, F Cocker, C Taylor, B Oldenburg, M Berk

(2015), Vol. 15, pp. 15-15, BMC Psychiatry, England, C1

journal

The impact of maternal smoking during pregnancy on depressive and anxiety behaviors in children: the Norwegian Mother and Child Cohort Study.

S Moylan, K Gustavson, S Øverland, E Karevold, F Jacka, J Pasco, M Berk

(2015), Vol. 13, pp. 24-24, BMC Medicine, England, C1

journal

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

S Kim, B Jeong, J Kim, I Shin, M Hwang, G Paul Amminger, B Nelson, M Berk, P McGorry, J Yoon

(2015), Vol. 226, pp. 368-375, Psychiatry research, Shannon, Ireland, C1

journal

N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

E Prado, M Maes, L Piccoli, M Baracat, D Barbosa, O Franco, S Dodd, M Berk, S Vargas Nunes

(2015), Redox report, Edinburgh, Scotland, C1

journal

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

G Morris, M Berk, K Walder, M Maes

(2015), Vol. 13, pp. 1-23, BMC Medicine, London, Eng., C1

journal

Online mindfulness-based intervention for late-stage bipolar disorder: pilot evidence for feasibility and effectiveness

G Murray, N Leitan, M Berk, N Thomas, E Michalak, L Berk, S Johnson, S Jones, T Perich, N Allen, M Kyrios

(2015), Vol. 178, pp. 46-51, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

An adjunctive antidepressant nutraceutical combination in treating major depression: study protocol and clinical considerations

J Sarris, C Stough, C Bousman, J Murphy, K Savage, D Smith, R Menon, S Chamoli, G Oliver, M Berk, G Byrne, C Ng, D Mischoulon

(2015), Vol. 2, pp. 49-56, Advances in integrative medicine, Amsterdam, The Netherlands, C1-1

journal

A brief review of exercise, bipolar disorder, and mechanistic pathways.

D Thomson, A Turner, S Lauder, M Gigler, L Berk, A Singh, J Pasco, M Berk, L Sylvia

(2015), Vol. 6, pp. 147-147, Frontiers in Psychology, Switzerland, C1

journal

Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy

E Callaly, K Walder, G Morris, M Maes, M Debnath, M Berk

(2015), Vol. 15, pp. 355-365, Mini-reviews in medicinal chemistry, Amsterdam, The Netherlands, C1

journal

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

G Morris, M Berk

(2015), Vol. 13, pp. 1-25, BMC medicine, London, Eng., C1

journal

Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder

C Bortolasci, H Vargas, S Vargas Nunes, L de Melo, M de Castro, E Moreira, S Dodd, D Barbosa, M Berk, M Maes

(2015), Vol. 179, pp. 148-155, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Influence of light exposure during early life on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, B Baune, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Wo Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, J Gottlieb, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, Â Miranda-Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 64, pp. 1-8, Journal of psychiatric research, Amsterdam, The Netherlands, C1

journal

Instruments that prospectively predict bipolar disorder - a systematic review.

A Ratheesh, M Berk, C Davey, P McGorry, S Cotton

(2015), Vol. 179, pp. 65-73, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Psychiatric disorders, psychotropic medication use and falls among women: an observational study

L Williams, J Pasco, A Stuart, F Jacka, S Brennan, A Dobbins, R Honkanen, H Koivumaa-Honkanen, P Rauma, M Berk

(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1

journal

Oxidant/antioxidant imbalance is an inherent feature of depression

M Talarowska, J Szemraj, M Berk, M Maes, P Ga?ecki

(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1

journal

Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies

A Ghanizadeh, A Singh, M Berk, M Torabi-Nami

(2015), Vol. 19, pp. 1-13, Expert opinion on therapeutic targets, Oxford, Eng., C1

journal

Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness

R Daglas, M Yücel, S Cotton, K Allott, S Hetrick, M Berk

(2015), Vol. 3, pp. 1-18, International Journal of Bipolar Disorders, Heidelberg, Germany, C1

journal

Tobacco use in bipolar disorder.

D Thomson, M Berk, S Dodd, M Rapado-Castro, S Quirk, P Ellegaard, L Berk, O Dean

(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1

journal

N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review

G Oliver, O Dean, D Camfield, S Blair-West, C Ng, M Berk, J Sarris

(2015), Vol. 13, pp. 12-24, Clinical psychopharmacology and neuroscience, Korea (South), C1

journal

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

M Maes, G Nowak, J Caso, J Leza, C Song, M Kubera, H Klein, P Galecki, C Noto, E Glaab, R Balling, M Berk

(2015), Molecular Neurobiology, C1

journal

Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study

A Singh, C Bousman, C Ng, K Byron, M Berk

(2015), Vol. 13, pp. 53-61, Clinical psychopharmacology and neuroscience, Korea (South), C1

journal

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Deepmala, J Slattery, N Kumar, L Delhey, M Berk, O Dean, C Spielholz, R Frye

(2015), Vol. 55, pp. 294-321, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study

N Hyde, S Dodd, K Venugopal, Purdie, M Berk, A O'Neil

(2015), Vol. 10, pp. 125-131, Current drug safety, San Francisco, Calif., C1

journal

Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?

B Panizzutti, C Gubert, A Schuh, P Ferrari, G Bristot, G Fries, R Massuda, J Walz, N Rocha, M Berk, A Teixeira, C Gama

(2015), Vol. 182, pp. 64-69, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages

A Ratheesh, S Cotton, J Betts, A Chanen, B Nelson, C Davey, P McGorry, M Berk, A Bechdolf

(2015), Vol. 183, pp. 45-48, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams

(2015), Vol. 15, pp. 177-185, Journal of Musculoskeletal and Neuronal Interactions, Greece, C1

journal

Mechanisms underlying neurocognitive dysfunctions in recurrent major depression

P Ga?ecki, M Talarowska, G Anderson, M Berk, M Maes

(2015), Vol. 21, pp. 1535-1547, Medical Science Monitor: international medical journal for clinical and experimental research, Warsaw, Poland, C1

journal

The putative role of viruses, bacteria, and chronic fungal biotoxin exposure in the genesis of intractable fatigue accompanied by cognitive and physical disability

G Morris, M Berk, K Walder, M Maes

(2015), Vol. In press, pp. 1-22, Molecular neurobiology, Clifton, N.J., C1

journal

Excessive daytime sleepiness and falls among older men and women: cross-sectional examination of a population-based sample

A Hayley, L Williams, G Kennedy, K Holloway, M Berk, S Brennan-Olsen, J Pasco

(2015), Vol. 15, pp. 74-74, BMC geriatrics, London, Eng., C1

journal

Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials

S Dodd, A Schacht, K Kelin, H Dueñas, V Reed, L Williams, F Quirk, G Malhi, M Berk

(2015), Vol. 76, pp. 702-711, Journal of clinical psychology, Weinheim, Germany, C1

journal

Evolution of optogenetic microdevices

R Kale, A Kouzani, K Walder, M Berk, S Tye

(2015), Vol. 2, pp. 1-11, Neurophotonics, Bellingham, W.A., C1

journal

Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder

S Kim, S Dodd, L Berk, J Kulkarni, A de Castella, P Fitzgerald, J Kim, J Yoon, M Berk

(2015), Vol. 12, pp. 349-355, Psychiatry Investigation, Seoul, Korea (South), C1

journal

Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis

A Carvalho, C Köhler, R McIntyre, C Knöchel, A Brunoni, M Thase, J Quevedo, B Fernandes, M Berk

(2015), Vol. 62, pp. 18-26, Psychoneuroendocrinology, Amsterdam, The Netherlands, C1

journal

Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function?

J Pasco, L Williams, F Jacka, N Stupka, S Brennan-Olsen, K Holloway, M Berk

(2015), Vol. 13, pp. 351-357, Current Osteoporosis Reports, New York, N.Y., C1

journal

The Association Between Use of Antidepressants and Bone Quality Using Quantitative Ultrasound.

P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams

(2015), pp. 1-7, Australian & New Zealand Journal of Psychiatry, C1-1

journal

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

S Smesny, B Milleit, M Schaefer, U Hipler, C Milleit, C Wiegand, J Hesse, C Klier, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Paul Amminger

(2015), Vol. 101, pp. 15-21, Prostaglandins leukot essent fatty acids, Amsterdam, The Netherlands, C1

journal

Radio frequency energy harvesting from a feeding source in a passive deep brain stimulation device for murine preclinical research

M Hosain, A Kouzani, S Tye, M Samad, R Kale, K Bennet, F Manciu, M Berk

(2015), Vol. 37, pp. 1020-1026, Medical engineering and physics, Amsterdam, The Netherlands, C1

journal

Antimanic-like activity of candesartan in mice: possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms

J de Souza Gomes, G de Souza, M Berk, L Cavalcante, F de Sousa, J Budni, D de Lucena, J Quevedo, A Carvalho, D Macêdo

(2015), Vol. 25, pp. 2086-2097, European neuropsychopharmacology, Amsterdam, The Netherlands, C1

journal

Citalopram and sertraline exposure compromises embryonic bone development

D Fraher, J Hodge, F Collier, J McMillan, R Kennedy, M Ellis, G Nicholson, K Walder, S Dodd, M Berk, J Pasco, L Williams, Y Gibert

(2015), Vol. In press, pp. 1-9, Molecular psychiatry, Hampshire, Eng., C1

journal

N-Acetyl Cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, placebo-controlled study

J Sarris, G Oliver, D Camfield, O Dean, N Dowling, D Smith, J Murphy, R Menon, M Berk, S Blair-West, C Ng

(2015), Vol. 29, pp. 801-809, CNS Drugs, Berlin, Germany, C1

journal

Symptoms of depression and difficulty initiating sleep from early adolescence to early adulthood: a longitudinal study

A Hayley, J Skogen, B Sivertsen, B Wold, M Berk, J Pasco, S Øverland

(2015), Vol. 38, pp. 1599-1606, Sleep, Darien, Ill., C1

journal

Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial

P Conus, M Berk, S Cotton, L Kader, C Macneil, M Hasty, K Hallam, M Lambert, B Murphy, P McGorry

(2015), Vol. 30, pp. 975-982, European psychiatry, Amsterdam, The Netherlands, C1-1

journal

Falls and depression in men: a population-based study

A Stuart, J Pasco, F Jacka, M Berk, L Williams

(2015), pp. 1-5, American journal of men's health, New York, N. Y., C1

journal

Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study

E Gliddon, S Lauder, L Berk, V Cosgrove, D Grimm, S Dodd, T Suppes, M Berk

(2015), Vol. 15, pp. 1-9, BMC psychiatry, London, Eng., C1

journal

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin.

A Quinn, O Dean, C Davey, M Kerr, S Harrigan, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, M Schäfer, E Mullen, S Hetrick, P McGorry, M Berk

(2015), pp. 1-10, Early intervention in psychiatry, London, Eng., C1

journal

The use of mixed methods in drug discovery: integrating qualitative methods into clinical trials

M Berk, R Otmar, O Dean, L Berk, E Michalak

(2015), pp. 59-73, Clinical trial design challenges in mood disorders, Amsterdam, The Netherlands, B1

chapter

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies

B Fernandes, M Molendijk, C Kohler,, J Soares, C Leite, R Machado-Vieria, T Ribeiro, J Silva, P Sales, J Quevedo, V Oertel-Knochel, E Vieta, A Gonzalez-Pinto, M Berk, A Carvalho

(2015), Vol. 13, pp. 1-22, BMC Medicine, London, Eng., C1

journal

The use of statins for the treatment of depression in patients with acute coronary syndrome

S Kim, K Bae, J Kim, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon

(2015), Vol. 5, pp. 1-7, Translational psychiatry, London, Eng., C1-1

journal

Wireless optogenetics: an exploration of portable microdevices for small animal photostimulation

R Kale, A Kouzani, M Berk, K Walder, J Berk, S Tye

(2015), Vol. 20, pp. 225-230, Procedia technology, Amsterdam, The Netherlands, C1

journal
2014

Investigating the predictive validity of an emergency department mental health triage tool

N Sands, S Elsom, M Berk, J Hosking, R Prematunga, M Gerdtz

(2014), Vol. 16, pp. 11-18, Nursing and health sciences, Milton, Qld., C1

journal

Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome

G Anderson, M Berk, M Maes

(2014), Vol. 129, pp. 83-97, Acta Psychiatrica Scandinavica, London, UK, C1

journal

The association between poor dental health and depression: findings from a large-scale, population-based study (the NHANES study)

A O?Neil, M Berk, K Venugopal, S Kim, L Williams, F Jacka

(2014), Vol. 36, pp. 266-270, General Hospital Psychiatry, Amsterdam, The Netherlands, C1

journal

Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications

G Anderson, M Berk, O Dean, S Moylan, M Maes

(2014), Vol. 28, CNS Drugs, Aukland, New Zealand, C1

journal

Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention

A Walker, Y Kim, J Price, R Kale, J McGillivray, M Berk, S Tye

(2014), Vol. 5, Frontiers in psychiatry, Lausanne, Switzerland, C1-1

journal

Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders

H Vargas, S Vargas Nunes, D Barbosa, M Vargas, A Cestari, S Dodd, K Venugopal, M Maes, M Berk

(2014), Vol. 102, pp. 65-71, Life sciences, Amsterdam, The Netherlands, C1

journal

Prevalence of excessive daytime sleepiness in a sample of the Australian adult population

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2014), Vol. 15, pp. 348-354, Sleep medicine, Amsterdam, The Netherlands, C1

journal

Risk stratification using data from electronic medical records better predicts suicide risks than clinician assessments

T Tran, W Luo, D Phung, R Harvey, M Berk, R Kennedy, S Venkatesh

(2014), Vol. 14, pp. 1-9, BMC psychiatry, London, Eng., C1

journal

Systematic review of N-acetylcysteine in the treatment of addictions

E Asevedo, A Mendes, M Berk, E Brietzke

(2014), Vol. 36, pp. 168-175, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1

journal

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

M Maes, G Anderson, M Kubera, M Berk

(2014), Vol. 18, pp. 495-512, Expert opinion on therapeutic targets, London, England, C1

journal

The efficacy of adjunctive N-Acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial

M Berk, O Dean, S Cotton, S Jeavons, M Tanious, K Kohlmann, K Hewitt, K Moss, C Allwang, I Schapkaitz, J Robbins, H Cobb, F Ng, S Dodd, A Bush, G Malhi

(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

Lowered plasma paraoxonase (PON) 1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder

C Bortolasci, H Odebrecht Vargas, A Souza-Nogueira, D Barbosa, E Moreira, S Obedrecht Vargas Nunes, M Berk, S Dodd, M Maes

(2014), Vol. 159, pp. 23-30, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania

J Kulkarni, M Berk, W Wang, L Mu, E Scarr, T Van Rheenen, R Worsely, C Gurvich, E Gavrilidis, A de Castella, P Fitzgerald, S David

(2014), Vol. 43, pp. 52-61, Psychoneuroendocrinology, Oxford, England, C1

journal

Neuroprogression in schizophrenia : pathways underpinning clinical staging and therapeutic corollaries

J Davis, S Moylan, B Harvey, M Maes, M Berk

(2014), Vol. 48, pp. 512-529, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Oxidative & nitrosative stress in depression: why so much stress?

S Moylan, M Berk, O Dean, Y Samuni, L Williams, A O'Neil, A Hayley, J Pasco, G Anderson, F Jacka, M Maes

(2014), Vol. 45, pp. 46-62, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Predominant polarity as a course specifier for bipolar disorder: a systematic review

A Carvalho, R McIntyre, D Dimelis, X Gonda, M Berk, P Nunes-Neto, D Cha, T Hyphantis, J Angst, K Fountoulakis

(2014), Vol. 163, pp. 56-64, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study

M Bauer, T Glenn, M Alda, O Andreasssen, E Angelopoulos, R Ardua, C Baethge, R Bauer, F Belliver, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagionlini, M Frye, K Fountoulaski, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsa, F Kapczinski, S Kliwicki, B Konig, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2014), Vol. 167, pp. 104-111, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD

T Deckersbach, A Peters, L Sylvia, A Urdahl, P Magalhaes, M Otto, E Frank, D Miklowitz, M Berk, G Kinryn, A Nierenberg

(2014), Vol. 171, pp. 178-186, American journal of psychiatry, Arlington, VA, C1

journal

Suicidal ideation and physical illness: Does the link lie with depression?

L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, L Williams

(2014), Vol. 152-154, pp. 422-426, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)

G Morris, M Berk, P Galacki, M Maes

(2014), Vol. 49, pp. 741-756, Molecular neurobiology, New York, N. Y., C1

journal

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder

S Kim, L Berk, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, G Amminger, M Berk

(2014), Vol. 166, pp. 243-248, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

journal

Lifestyle medicine for depression

J Sarris, A O'Neil, C Coulson, I Schwitzer, M Berk

(2014), Vol. 14, pp. 1-13, BMC Psychiatry, London, England, C1

journal

Comparison of self-report and structured clinical interview in the identification of depression

A Stuart, J Pasco, F Jacka, S Brennan, M Berk, L Williams

(2014), Vol. 55, pp. 866-869, Comphrensive psychiatry, Amsterdam, The Netherlands, C1

journal

Attributions of responsibility and recovery within a no-fault insurance compensation system

J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern

(2014), Vol. 59, pp. 247-255, Rehabilitation psychology, Washington DC, C1

journal

Predicting bipolar disorder on the basis of phenomenology : implications for prevention and early intervention

G Malhi, D Bargh, C Coulston, P Das, M Berk

(2014), Vol. 16, pp. 455-470, Bipolar disorders, Copenhagen, Denmark, C1

journal

Personality disorders and physical comorbidities in adults from the United States: data from the national epidemiologic survey on alcohol and related conditions

S Quirk, R El-Gabalawy, S Brennan, J Bolton, J Sareen, M Berk, A Chanen, J Pasco, L Williams

(2014), pp. 1-14, Social psychiatry and psychiatric epidemiology, Amsterdam, The Netherlands, C1

journal

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression

O Dean, A Turner, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, Y Samuni, M Tanious, N Dowling, A Waterdrinker, D Smith, M Berk

(2014), Vol. 0, pp. 1-10, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1

journal

Assessing regional cerebral blood flow in depression using 320-slice computed tomography

Y Wang, H Zhang, S Tang, X Liu, A O'Neil, A Turner, F Chai, F Chen, M Berk

(2014), Vol. 9, pp. 1-10, PLoS One, San Francisco, Cal., C1

journal

Adipokines as emerging depression biomarkers: a systematic review and meta-analysis

A Carvalho, D Rocha, R McIntyre, L Mesquita, C Köhler, T Hyphantis, P Sales, R Machado-Vieira, M Berk

(2014), Vol. 59, pp. 28-37, Journal of psychiatric research, Oxford, England, C1

journal

Relationship between diet and mental health in children and adolescents: a systematic review

A O'Neil, S Quirk, S Housden, S Brennan, L Williams, J Pasco, M Berk, F Jacka

(2014), Vol. 104, pp. e31-e42, American journal of public health, Washington, DC, C1

journal

Paraoxonase 1 status and interactions between Q192R functional genotypes by smoking contribute significantly to total plasma radical trapping antioxidant potential.

C Bortolasci, M Maes, H Vargas, A Souza-Nogueira, E Moreira, S Nunes, M Berk, S Dodd, D Barbosa

(2014), Vol. 581, pp. 46-51, Neuroscience letters, Shannon, Ireland, C1

journal

The impact of insight in a first-episode mania with psychosis population on outcome at 18 months

L Smith, C Shelton, M Berk, M Hasty, S Cotton, L Henry, R Daglas, E Gentle, P McGorry, C Macneil, P Conus

(2014), Vol. 167, pp. 74-79, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis

S Kim, M Schäfer, C Klier, M Berk, S Rice, K Allott, C Bartholomeusz, S Whittle, E Pilioussis, C Pantelis, P McGorry, G Amminger

(2014), Vol. 158, pp. 39-44, Schizophrenia Research, Amsterdam, The Netherlands, C1

journal

Application of the gradient boosted method in randomised clinical trials: participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo

S Dodd, M Berk, K Kelin, Q Zhang, E Eriksson, W Deberdt, J Craig Nelson

(2014), Vol. 168, pp. 284-293, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Pop, heavy metal and the blues: secondary analysis of persistent organic pollutants (POP), heavy metals and depressive symptoms in the NHANES National Epidemiological Survey

M Berk, L Williams, A Andreazza, J Pasco, S Dodd, F Jacka, S Moylan, E Reiner, P Magalhaes

(2014), Vol. 4, pp. 1-9, BMJ Open, London, England, C1

journal

Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial.

A Ghanizadeh, Z Rezaee, S Dehbozorgi, M Berk, S Akhondzadeh

(2014), Vol. 219, pp. 431-435, Psychiatry Research, Ireland, C1

journal

Data Integration Protocol In Ten-steps (DIPIT) : a new standard for medical researchers

J Dipnall, M Berk, F Jacka, L Williams, S Dodd, J Pasco

(2014), Vol. 69, pp. 237-246, Methods, Amsterdam, The Netherlands, C1

journal

SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study

M Pizzo de Castro, M Maes, R Guembarovski, C Ariza, E Reiche, H Vargas, M Vargas, L de Melo, S Dodd, M Berk, M Watanabe, S Nunes

(2014), Vol. 15, pp. 1-9, BMC Genetics, London, England, C1

journal

Quality of life in bipolar and schizoaffective disorder - a naturalistic approach.

M Martin-Subero, L Berk, S Dodd, V Kamalesh, M Maes, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2014), Vol. 55, pp. 1540-1545, Comprehensive Psychiatry, Malden, Mass., C1

journal

Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

M Debnath, M Berk

(2014), Vol. 40, pp. 1412-1421, Schizophrenia Bulletin, Oxford , England, C1

journal

Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence

S Odebrecht Vargas Nunes, M Pizzo de Castro, M Ehara Watanabe, R Losi Guembarovski, H Odebrecht Vargas, E Reiche, H Kaminami Morimoto, S Dodd, M Berk

(2014), Vol. 24, pp. 87-93, Psychiatric genetics, Philadelphia, PA, C1

journal

Stage managing bipolar disorder.

M Berk, L Berk, S Dodd, S Cotton, C Macneil, R Daglas, P Conus, A Bechdolf, S Moylan, G Malhi

(2014), Vol. 16, pp. 471-477, Bipolar Disorders, Malden, Mass., C1

journal

Age of onset, course of illness, and response to psychotherapy for bipolar depression

A Peters, L Sylvia, P Magalhaes, D Miklowitz, E Frank, M Otto, M Berk, A Nierenberg, T Deckersbach

(2014), Vol. 16, pp. 44-44, ISBD 2014 : Proceedings of the 16th Annual Conference of the International Society for Bipolar Disorders, Seoul, South Korea, E1-1

conference

The integrative management of treatment-resistant depression: a comprehensive review and perspectives.

A Carvalho, M Berk, T Hyphantis, R McIntyre

(2014), Vol. 83, pp. 70-88, Psychotherapy and psychosomatics, Basel, Switzerland, C1

journal

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial

A Ghanizadeh, A Sahraeizadeh, M Berk

(2014), Vol. 45, pp. 185-192, Child Psychiatry & Human Development, New York, NY, C1

journal

The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study

A Bechdolf, A Ratheesh, S Cotton, B Nelson, A Chanen, J Betts, T Bingmann, A Yung, M Berk, P McGorry

(2014), Vol. 16, pp. 493-504, Bipolar Disorders, Malden, Mass., C1

journal

Atypical antipsychotic agents; peas in a pod or chalk and cheese?

A Singh, A Nierenberg, L Yatham, M Berk

(2014), Vol. 12, pp. 1-4, BMC Medicine, London, England, C1

journal

Staging systems in bipolar disorder: An International Society for Bipolar Disorders Task Force Report

F Kapczinski, P Magalhães, V Balanzá-Martinez, V Dias, S Frangou, C Gama, A Gonzalez-Pinto, I Grande, K Ha, M Kauer-Sant'Anna, M Kunz, R Kupka, M Leboyer, C Lopez-Jaramillo, R Post, J Rybakowski, J Scott, S Strejilevitch, M Tohen, G Vazquez, L Yatham, E Vieta, M Berk

(2014), Vol. 130, pp. 354-363, Acta Psychiatrica Scandinavica, Malden, United States, C1

journal

The Glutathione System: a new drug target in neuroimmune disorders

G Morris, G Morris, G Anderson, G Anderson, O Dean, O Dean, M Berk, M Berk, P Galecki, P Galecki, M Martin-Subero, M Martin-Subero, M Maes, M Maes

(2014), Vol. 50, pp. 1059-1084, Molecular neurobiology, New York, N. Y., C1

journal

Excessive daytime sleepiness and body composition: a population-based study of adults

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2014), Vol. 9, pp. 1-8, PLoS One, San Francisco, CA, C1

journal

Association between attributions of responsibility for motor vehicle crashes, depressive symptoms, and return to work

J Thompson, M O'Donnell, L Stafford, T Nordfjaern, M Berk

(2014), Vol. 59, pp. 376-385, Rehabilitation Psychology, Washington, D.C., United States, C1

journal

Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S)

S Sarró, M Madre, P Fernández-Corcuera, M Valentí, J Goikolea, E Pomarol-Clotet, M Berk, B Amann

(2014), Vol. 172, pp. 110-115, Journal of Affective Disorders, Amsterdam , Netherlands, C1

journal

Age at onset, course of illness and response to psychotherapy in bipolar disorder: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

A Peters, L Sylvia, P Da Silva Magalhães, D Miklowitz, E Frank, M Otto, N Hansen, D Dougherty, M Berk, A Nierenberg, T Deckersbach

(2014), Vol. 44, pp. 3455-3467, Psychological medicine, Cambridge, Eng., C1

journal

Affective and content analysis of online depression communities

T Nguyen, D Phung, B Dao, S Venkatesh, M Berk

(2014), Vol. 5, pp. 217-226, IEEE Transactions on Affective Computing, Piscataway, N.J, C1

journal

Association between alcohol consumption and self-reported depression among elderly Australian men

C Coulson, L Williams, M Berk, D Lubman, S Quirk, J Pasco

(2014), Vol. 2, pp. 3-8, Geriatric Mental Health Care, Amsterdam, The Netherlands, C1

journal

Biomarkers and clinical staging in psychiatry

P McGorry, M Keshavan, S Goldstone, P Amminger, K Allott, M Berk, S Lavoie, C Pantelis, A Yung, S Wood, I Hickie

(2014), Vol. 13, pp. 211-223, World psychiatry, Oxford, England, C1

journal

High-impact child abuse may predict risk of elevated suicidality during antidepressant initiation

A Singh, C Bousman, C Ng, M Berk

(2014), Vol. 48, pp. 124-124, RANZCP 2014 : Evolving landscapes in mental health: interface & interaction : Proceedings of Congress 2014, Perth, W.A., E1-1

conference

Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity

C Bortolasci, H Vargas, A Souza-Nogueira, E Gastaldello Moreira, S Vargas Nunes, M Berk, S Dodd, D Barbosa, M Maes

(2014), Vol. 19, pp. 232-241, Redox report, Leeds, England, C1

journal

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.

C Davey, A Chanen, S Cotton, S Hetrick, M Kerr, M Berk, O Dean, K Yuen, M Phelan, A Ratheesh, M Schäfer, G Amminger, A Parker, D Piskulic, S Harrigan, A Mackinnon, B Harrison, P McGorry

(2014), Vol. 15, pp. 1-9, Trials, London, Eng., C1

journal

The impact of past direct-personal traumatic events on 12-month outcome in first episode psychotic mania: trauma and early psychotic mania

R Daglas, P Conus, S Cotton, C Macneil, M Hasty, L Kader, M Berk, K Hallam

(2014), Vol. 48, pp. 1017-1024, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

journal

Optimizing delivery of recovery-oriented online self-management strategies for bipolar disorder : a review

N Leitan, E Michalak, L Berk, M Berk, G Murray

(2014), pp. 1-13, Bipolar Disorders, Malden, United States, C1

journal

Oxidative stress markers, cognitive functions, and psychosocial functioning in bipolar disorder : an empirical cross-sectional study

Ö Aydemir, Z Çubukçuo?lu, S Erdin, C Ta?, E Onur, M Berk

(2014), Vol. 36, pp. 293-297, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1

journal

Statin use and risk of depression: a Swedish national cohort study

C Redlich, M Berk, L Williams, J Sundquist, K Sundquist, X Li

(2014), Vol. 14, pp. 1-9, BMC Psychiatry, London, Eng., C1

journal

The effects of escitalopram on myocardial apoptosis and the expression of Bax and Bcl-2 during myocardial ischemia/reperfusion in a model of rats with depression.

Y Wang, H Zhang, F Chai, X Liu, M Berk

(2014), Vol. 14, pp. 1-7, BMC Psychiatry, London, England, C1

journal

Cognitive dysfunction in depression - pathophysiology and novel targets

A Carvalho, K Miskowiak, T Hyphantis, C Kohler, G Alves, B Bortolato, P Sales, R Machado-Vieira, M Berk, R McIntyre

(2014), Vol. 13, pp. 1-17, CNS & Neurological Disorders - Drug Targets, Bussum, Netherlands, C1

journal

Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders.

S Vargas Nunes, M Pizzo de Castro, E Moreira, R Guembarovski, D Barbosa, H Vargas, L Piccoli de Melo, C Bortolasci, M Watanabe, S Dodd, M Berk, M Maes

(2014), Vol. 585C, pp. 132-137, Neuroscience letters, Shannon, Ireland, C1

journal

Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome

M Maes, J Leunis, M Geffard, M Berk

(2014), Vol. 35, pp. 445-453, Neuroendocrinology Letters, Sweden, C1

journal

Relationship between membrane fatty acids and cognitive function in individuals at ultra-high risk for psychosis

S Kim, M Schäfer, C Klier, M Berk, S Rice, K Allot, C Bartholomeusz, S Whittle, E Pilioussis, C Pantelis, P McGorry, G Amminger

(2014), Vol. 8, pp. 166-166, IEPA 2014 : To the new horizon : Proceedings of the 9th International Conference on Early Psychosis, Tokyo, Japan, E1-1

conference

The association between dietary patterns, diabetes and depression.

J Dipnall, J Pasco, D Meyer, M Berk, L Williams, S Dodd, F Jacka

(2014), Vol. 174, pp. 215-224, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

journal

Treatment implications of predominant polarity and the polarity index: a comprehensive review.

A Carvalho, J Quevedo, R McIntyre, M Soeiro-de-Souza, K Fountoulakis, M Berk, T Hyphantis, E Vieta

(2014), Vol. 18, International Journal of Neuropsychopharmacology, England, C1

journal

e-Mental health for mood and anxiety disorders in general practice

J Orman, B O'Dea, F Shand, M Berk, J Proudfoot, H Christensen

(2014), Vol. 43, pp. 832-837, Australian family physician, Melbourne, Vic., C1

journal

Construct validity of the Experiences of Therapy Questionnaire (ETQ)

G Parker, A Paterson, K Fletcher, G McClure, M Berk

(2014), Vol. 14, pp. 1-6, BMC psychiatry, London, England, C1-1

journal

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial.

O Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, A Sughondhabirom, S Tangwongchai, C Ng, N Dowling, G Malhi, M Berk

(2014), Vol. 12, pp. 180-188, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1

journal

Development of a compact rectenna for wireless powering of a head-mountable deep brain stimulation device

M Hosain, A Kouzani, S Tye, O Abulseoud, A Amiet, A Galehdar, A Kaynak, M Berk

(2014), Vol. 2, pp. 1-13, IEEE journal of translational engineering in health and medicine, Piscataway, N.J., C1

journal

The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study

A Bechdolf, A Rateesh, S Cotton, B Nelson, A Chanen, J Betts, T Bingmann, A Yung, M Berk, P McGorry

(2014), Vol. 16, pp. 493-504, Bipolar Disorders: an international journal of psychiatry and neurosciences, London, Eng., C1-1

journal
2013

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

S Moylan, M Maes, N Wray, M Berk

(2013), Vol. 18, pp. 595-606, Molecular psychiatry, London, England, C1

journal

Development of an online intervention for bipolar disorder. www.moodswings.net.au

S Lauder, A Chester, D Castle, S Dodd, L Berk, B Klein, D Austin, M Gilbert, J Chamberlain, G Murray, C White, L Piterman, M Berk

(2013), Vol. 18, pp. 155-165, Psychology, health and medicine, Oxon, England, C1

journal

The sick role, illness cognitions and outcomes in bipolar disorder

M Berk, L Berk, S Dodd, P Fitzgerald, A de Castella, S Filia, K Filia, A Brnabic, K Kelin, W Montgomery, J Kulkarni, L Stafford

(2013), Vol. 146, pp. 146-149, Journal of affective disorders, Amsterdam, Netherlands, C1

journal

Clinical characteristics and smoking cessation : an analysis of sex and depressive disorders differences

S Nunes, M de Castro, H Vargasa, M Vargas, I de Batista Fonseca, S Dodd, M Berk

(2013), Vol. 12, pp. 158-165, Addictive disorders & their treatment, Philadelphia, PA, C1

journal

Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women

F Jacka, J Pasco, L Williams, B Meyer, R Digger, M Berk

(2013), Vol. 109, pp. 2059-2066, British journal of nutrition, Cambridge, England, C1

journal

Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach

A Ghanizadeh, M Berk, H Farrashbandi, A Alavi shoushtari, K Villagonzalo

(2013), Vol. 13, pp. 515-519, Mitochondrion, Amsterdam, The Netherlands, C1

journal

Diet quality and mental health problems in adolescents from East London : a prospective study

F Jacka, C Rothon, S Taylor, M Berk, S Stansfeld

(2013), Vol. 48, pp. 1297-1306, Social psychiatry and psychiatric epidemiology, Heidelberg, Germany, C1

journal

The nocebo effect : a clinicians guide

J Data-Franco, M Berk

(2013), Vol. 47, pp. 617-623, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders

L Williams, J Pasco, F Jacka, J Hodge, M Kotowicz, M Berk

(2013), Vol. 146, pp. 395-400, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Putative neuroprotective agents in neuropsychiatric disorders

S Dodd, M Maes, G Anderson, O Dean, S Moylan, M Berk

(2013), Vol. 42, pp. 135-145, Progress in neuro-psychopharmacology and biological psychiatry, United States, C1

journal

Neurocognitive functioning in the prodrome of mania - an exploratory study

A Ratheesh, A Lin, B Nelson, S Wood, W Brewer, J Betts, M Berk, P McGorry, A Yung, A Bechdolf

(2013), Vol. 147, pp. 441-445, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function

J Hodge, Y Wang, M Berk, F Collier, T Fernandes, M Constable, J Pasco, S Dodd, G Nicholson, R Kennedy, L Williams

(2013), Vol. 74, pp. 32-39, Biological psychiatry, Amsterdam, The Netherlands, C1

journal

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

G Anderson, M Maes, M Berk

(2013), Vol. 42, pp. 101-114, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1

journal

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine

M Moller, J Du Preez, F Viljoen, M Berk, R Emsley, B Harvey

(2013), Vol. 30, pp. 156-167, Brain, behavior, and immunity, Marylands Heights, Mo., C1

journal

Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression

M Maes, M Kubera, I Mihaylova, M Geffard, P Galecki, J Leunis, M Berk

(2013), Vol. 149, pp. 23-29, Journal of affective disorders, Amsterdam, Netherlands, C1

journal

Development of a measure quantifying adverse psychotherapeutic ingredients : The Experiences of Therapy Questionnaire (ETQ)

G Parker, K Fletcher, M Berk, A Paterson

(2013), Vol. 206, pp. 293-301, Psychiatry research, Shannon, Ireland, C1-1

journal

Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels

A Walker, S Burnett, K Hasebe, J McGillivray, L Gray, S McGee, K Walder, M Berk, S Tye

(2013), Vol. 242, pp. 76-83, Behavioural brain research, Amsterdam, The Netherlands, C1

journal

Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD : a systematic review of non-controlled and controlled trials

A Ghanizadeh, R Freeman, M Berk

(2013), Vol. 8, pp. 2-8, Reviews on recent clinical trials, Bussum, The Netherlands, C1

journal

The promise of N-acetylcysteine in neuropsychiatry

M Berk, G Malhi, L Gray, O Dean

(2013), Vol. 34, pp. 167-177, Trends in pharmacological sciences, Oxford, England, C1

journal

Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo

P Das, M Tanious, K Fritz, S Dodd, O Dean, M Berk, G Malhi

(2013), Vol. 47, pp. 347-354, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Biomarkers in bipolar disorder : a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

B Frey, A Andreazza, J Houenou, S Jamain, B Goldstein, M Frye, M Leboyer, M Berk, G Malhi, C Lopez-Jaramillo, V Taylor, S Dodd, S Frangou, G Hall, B Fernandes, M Kauer-Sant'Anna, L Yatham, F Kapczinski, L Young

(2013), Vol. 47, pp. 321-332, Australian and New Zealand journal of psychiatry, London, England, C1-1

journal

Lifestyle management of unipolar depression

M Berk, J Sarris, C Coulson, F Jacka

(2013), Vol. 127, pp. 38-54, Acta psychiatrica scandinavica, Malden, Mass., C1-1

journal

A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania

P Vieira da Silva Magalhaes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2013), Vol. 47, pp. 564-568, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Differences between first episode schizophrenia and schizoaffective disorder

S Cotton, M Lambert, B Schimmelmann, A MacKinnon, J Gleeson, M Berk, L Hides, A Chanen, J Scott, D Schottle, P McGorry, P Conus

(2013), Vol. 147, pp. 169-174, Schizophrenia research, Amsterdam, The Netherlands, C1

journal

Pharmacological management of unipolar depression

G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz

(2013), Vol. 127, pp. 6-23, Acta psychiatrica scandinavica, Malden, Mass., C1

journal

The relationship between excessive daytime sleepiness and depressive and anxiety disorders in women

A Hayley, L Williams, M Berk, G Kennedy, F Jacka, J Pasco

(2013), Vol. 47, pp. 772-778, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Physical comorbidities in men with mood and anxiety disorders: a population-based study

L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, S Brennan, L Williams

(2013), Vol. 11, pp. 1-9, BMC medicine, London, England, C1

journal

Extreme attributions predict the course of bipolar depression : results from the STEP-BD randomized controlled trial of psychosocial treatment

J Strange, L Sylvia, P Vieira da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, A Nierenberg, T Deckersbach

(2013), Vol. 74, pp. 249-255, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

Gender differences in first episode psychotic mania

S Cotton, M Lambert, M Berk, B Schimmelmann, F Butselaar, P McGorry, P Conus

(2013), Vol. 13, pp. 1-8, BMC psychiatry, London, England, C1

journal

Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness

M Berk, M Berk, O Dean, O Dean, H Drexhage, H Drexhage, J McNeil, J McNeil, S Moylan, S Moylan, A O'Neil, A O'Neil, C Davey, C Davey, L Sanna, L Sanna, M Maes, M Maes

(2013), Vol. 11, pp. 1-17, BMC medicine, London, England, C1

journal

How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders : a critical review of biological pathways

S Moylan, F Jacka, J Pasco, M Berk

(2013), Vol. 3, pp. 302-326, Brain and behavior, London, England, C1

journal

The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction

Y Wang, X Liu, D Zhang, J Chen, S Liu, M Berk

(2013), Vol. 11, pp. 1-9, BMC medicine, London, England, C1

journal

Socio-demographic lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns

T Nordfjaern, O Bjerkeset, G Bratberg, S Moylan, M Berk, R Grawe

(2013), Vol. 68, pp. 107-116, Nordic journal of psychiatry, Oslo, Norway, C1

journal

The impact of smoking in adolescence on early adult anxiety symptoms and the relationship between infant vulnerability factors for anxiety and early adult anxiety symptoms : The TOPP Study

S Moylan, K Gustavson, E Karevold, S Overland, F Jacka, J Pasco, M Berk

(2013), Vol. 8, PLoS one, San Francisco, Calif., C1

journal

Psychomotor depressive symptoms may differentially respond to venlafaxine

A Singh, C Bousman, C Ng, K Byron, M Berk

(2013), Vol. 28, pp. 121-126, International clinical psychopharmacology, Philadelphia, Pa., C1

journal

Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours

S Moylan, H Eyre, M Maes, B Baune, F Jacka, M Berk

(2013), Vol. 37, pp. 573-584, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Oxidative stress and inflammatory markers are associated with depression and nicotine dependence

H Vargas, S Nunes, M de Castro, M Vargas, D Barbosa, C Bortolasci, K Venugopal, S Dodd, M Berk

(2013), Vol. 544, pp. 136-140, Neuroscience letters, Amsterdam, The Netherlands, C1

journal

A randomised, controlled trial of a dietary intervention for adults with major depression (the 'SMILES' trial): study protocol

A O'Neil, M Berk, C Itsiopoulos, D Castle, R Opie, J Pizzinga, L Brazionis, A Hodge, C Mihalopoulos, M Chatterton, O Dean, F Jacka

(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1

journal

Obesity and the relationship with positive and negative affect

J Pasco, L Williams, F Jacka, S Brennan, M Berk

(2013), Vol. 47, pp. 477-482, Australian & New Zealand journal of psychiatry, London, England, C1

journal

Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

S Smesny, B Milleit, U Hipler, C Milleit, M Schafer, C Klier, C Holub, I Holzer, G Berger, M Otto, I Nenadic, M Berk, P McGorry, H Sauer, G Amminger

(2013), Vol. 19, pp. 317-324, Molecular psychiatry, London, England, C1

journal

Prevention of common mental disorders: what can we learn from those who have gone before and where do we go next?

F Jacka, N Reavley, A Jorm, J Toumbourou, A Lewis, M Berk

(2013), Vol. 47, pp. 920-929, Australian & New Zealand journal of psychiatry, London, England, C1

journal

The association between diet quality, dietary patterns and depression in adults: a systematic review

S Quirk, L Williams, A O'Neil, J Pasco, F Jacka, S Housden, M Berk, S Brennan

(2013), Vol. 13, pp. 1-22, BMC psychiatry, London, England, C1

journal

The chemistry and biological activities of N-acetylcysteine

Y Samuni, S Goldstein, O Dean, M Berk

(2013), Vol. 1830, pp. 4117-4129, Biochim biophys acta, Amsterdam, Netherlands, C1

journal

Socioeconomic status and quality of life in population-based Australian men: data from the Geelong Osteoporosis Study

S Brennan, S Brennan, L Williams, L Williams, M Berk, M Berk, J Pasco, J Pasco

(2013), Vol. 37, pp. 226-232, Australian and New Zealand journal of public health, Chichester, England, C1-1

journal

Alcohol consumption and body composition in a population-based sample of elderly Australian men

C Coulson, L Williams, S Brennan, M Berk, M Kotowicz, D Lubman, J Pasco

(2013), Vol. 25, pp. 183-192, Aging clinical and experimental research, Cham, Switzerland, C1

journal

Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts

H Vargas, S Vargas Nunes, M de Castro, C Bortolasci, D Barbosa, H Morimoto, K Venugopal, S Dodd, M Maes, M Berk

(2013), Vol. 150, pp. 923-930, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder

S Dodd, M Berk, K Kelin, M Mancini, A Schacht

(2013), Vol. 150, pp. 344-349, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in women

L Sanna, A Stuart, M Berk, J Pasco, P Girardi, L Williams

(2013), Vol. 13, pp. 1-6, BMC psychiatry, London, England, C1

journal

Design and analysis of an antenna for wireless energy harvesting in head-mountable DBS device

M Hosain, A Kouzani, S Tye, O Abulseoud, M Berk

(2013), pp. 3078-3081, EMBC 2013 : Proceedings of the 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Osaka, Japan, E1-1

conference

Online social capital : mood, topical and psycholinguistic analysis

T Nguyen, B Dao, D Phung, S Venkatesh, M Berk

(2013), pp. 449-456, ICWSM 2013 : Proceedings of the 7th AAAI International Conference on Weblogs and Social Media, Cambridge, Massachusetts, E1

conference

A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) and sickness behavior

G Morris, G Anderson, P Galecki, M Berk, M Maes

(2013), Vol. 11, pp. 1-19, BMC medicine, London, England, C1-1

journal

DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions

C Nemeroff, D Weinberger, M Rutter, H MacMillan, R Bryant, S Wessely, D Stein, C Pariante, F Seemuller, M Berk, G Malhi, M Preisig, M Brune, P Lysaker

(2013), Vol. 11, pp. 202-220, BMC medicine, London, England, C1

journal

N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats

M Moller, J Du Preez, F Viljoen, M Berk, B Harvey

(2013), Vol. 28, pp. 687-696, Metabolic brain disease, New York, N. Y., C1

journal

Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia

A Ghanizadeh, M Berk

(2013), Vol. 3, pp. 1-6, Medical gas research, London, England, C1

journal

Clock face drawing test performance in children with ADHD

A Ghanizadeh, S Safavi, M Berk

(2013), Vol. 4, pp. 50-56, Basic and clinical neuroscience, Tehran, Iran, C1

journal

Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: the HUNT cohort study

T Nordfjaern, O Bjerkeset, S Moylan, M Berk, R Grawe

(2013), Vol. 38, pp. 2575-2580, Addictive behaviors, Amsterdam, The Netherlands, C1

journal

Altered cardiac autonomic nervous function in depression

Y Wang, X Zhao, A O'Neil, A Turner, X Liu, M Berk

(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1

journal

Cardiac-self efficacy predicts adverse outcomes in coronary artery disease (CAD) patients

A O'Neil, M Berk, J Davis, L Stafford

(2013), Vol. 5, pp. 6-14, Health, London, England, C1

journal

DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

R McIntyre, M Tohen, M Berk, J Zhao, E Weiller

(2013), Vol. 150, pp. 378-383, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence

S Nunes, H Vargas, E Prado, D Barbosa, L Picoli de Melo, S Moylan, S Dodd, M Berk

(2013), Vol. 37, pp. 1336-1345, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

A low power micro deep brain stimulation device for murine preclinical research

A Kouzani, O Abulseoud, S Tye, M Hosain, M Berk

(2013), Vol. 1, pp. 1-9, IEEE journal of translational engineering in health and medicine, Piscataway, N.J., C1

journal

The international society for bipolar disorders (ISBD) task force report on antidepressant use in bipolar diosrders

I Pacchiarotti, D Bond, R Baldessarini, W Nolen, H Grunze, R Licht, R Post, M Berk, G Goodwin, G Sachs, L Tondo, R Findling, E Youngstrom, M Tohen, J Undurraga, A Gonzalez-Pinto, J Goldberg, A Yildiz, L Altshuler, J Calabrese, P Mitchell, M Thase, A Koukopoulos, F Colom, M Frye, G Malhi, K Fountoulaskis, G Vazquez, R Perlis, T Ketter, F Cassidy, H Akiskal, J Azorin, M Valenti, D Mazzei, B Lafer, T Kato, L Mazzarini, A Martinez-Aran, G Parker, D Souery, A Ozerdem, S McElroy, P Girardi, M Bauer, L Yatham, C Zarate, A Nierenberg, B Birmaher, S Kanba, R El-Mallakh, A Serretti, Z Rihmer, A Young, G Kotzalidis, G MacQueen, C Bowden, S Ghaemi, C Lopez-Jaramillo, J Rybakowski, H Kyooseob, G Perugi, S Kasper, J Amsterdam, R Hirschfeld, F Kapczinski, E Vieta

(2013), Vol. 170, pp. 1-14, American journal of psychiatry, Arlington, Virginia, C1

journal

Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study clinical guidance

F Jacka, E Ystrom, A Brantsaeter, E Karevold, C Roth, M Haugen, H Meltzer, S Schjolberg, M Berk

(2013), Vol. 52, pp. 1038-1047, Journal of the American academy of child & pdolescent psychiatry, Amsterdam, The Netherlands, C1

journal

Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs

F Giorlando, J Teister, S Dodd, M Udina, M Berk

(2013), Vol. 8, pp. 175-180, Current drug safety, Bussum, The Netherlands, C1

journal

Emerging pharmacotherapy for cancer patients with cognitive dysfunction

J Davis, F Ahlberg, M Berk, D Ashley, M Khasraw

(2013), Vol. 13, BMC neurology, London, England, C1

journal

N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial

A Ghanizadeh, N Derakhshan, M Berk

(2013), Vol. 12, pp. 1-6, Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, Bussum, Netherlands, C1

journal

Antidepressant pharmacogenetics

A Singh, C Bousman, C Ng, M Berk

(2013), Vol. 27, pp. 43-51, Current Opinion in Psychiatry, Philadelphia, PA, C1

journal

So depression is an inflammatory disease, but where does the inflammation come from?

M Berk, M Berk, L Williams, L Williams, F Jacka, F Jacka, A O'Neil, A O'Neil, J Pasco, J Pasco, S Moylan, S Moylan, N Allen, N Allen, A Stuart, A Stuart, A Hayley, A Hayley, M Byne, M Byne, M Maes, M Maes

(2013), Vol. 11, pp. 1-16, BMC medicine, London, UK, C1-1

journal

Atopic disorders and depression: Findings from a large, population-based study

L Sanna, A Stuart, J Pasco, F Jacka, M Berk, M Maes, A O'Neil, P Girardi, L Williams

(2013), Vol. 155, pp. 261-265, Journal of Affective Disorders, Amsterdam, Netherlands, C1

journal

Depression following fracture in women: a study of age-matched cohorts

L Williams, M Berk, M Henry, A Stuart, S Brennan, F Jacka, J Pasco

(2013), Vol. 4, BMJ open, London, England, C1

journal

World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

M Bauer, A Pfennig, E Severus, P Whybrow, J Angst, H Moller, M Berk

(2013), Vol. 14, pp. 334-385, World journal of biological psychiatry, London, England, C1-1

journal

Potential mechanisms of action of lithium in bipolar disorder : current understanding

G Malhi, M Tanious, P Das, C Coulston, M Berk

(2013), Vol. 27, pp. 135-153, CNS drugs, Auckland, New Zealand, C1-1

journal

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder

L Berk, M Berk, S Dodd, C Kelly, S Cvetkovski, A Jorm

(2013), Vol. 11, pp. 1-13, BMC medicine, London, Eng., C1-1

journal

To a broader concept of remission: rating the health-related quality of life in bipolar disorder

M Subero, L Berk, S Dodd, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2013), Vol. 150, pp. 673-676, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

A Singh, C Bousman, C Ng, M Berk

(2013), Vol. 47, pp. 1191-1195, Australian & New Zealand journal of psychiatry, London, Eng., C1-1

journal

Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressants

J Nelson, Q Zhang, K Kelin, E Eriksson, W Deberdt, M Berk

(2013), Vol. 29, pp. 827-833, Current medical research and opinion, London, Eng., C1-1

journal

Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression

G Anderson, M Kubera, W Duda, W Laso?, M Berk, M Maes

(2013), Vol. 65, pp. 1647-1654, Pharmacological reports, Amsterdam, The Netherlands, C1-1

journal

Difficult-to-treat depression

D Castle, L Piterman, M Berk

(2013), Vol. 199, pp. S4-S5, The medical journal of australia, Australia, C1-1

journal

Tobacco smoking predicts depression and poorer quality of life in heart disease

L Stafford, M Berk, H Jackson

(2013), Vol. 13, pp. 1-10, BMC cardiovascular disorders, London, Eng., C1-1

journal

Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder

J Stange, L Sylvia, P Magalhães, E Frank, M Otto, D Miklowitz, M Berk, A Nierenberg, T Deckersbach

(2013), Vol. 47, pp. 1329-1336, Journal of psychiatric research, Amsterdam, The Netherlands, C1-1

journal

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications

G Morris, G Anderson, M Berk, M Maes

(2013), Vol. 48, pp. 883-903, Molecular neurobiology, New York, N.Y., C1-1

journal

Safe and effective use of lithium

G Malhi, M Tanious, D Bargh, P Das, M Berk

(2013), Vol. 36, pp. 18-21, Australian prescriber, Surry Hills, N.S.W., C1-1

journal

An integrated framework for suicide risk prediction

T Tran, Q Phung, W Luo, R Harvey, M Berk, S Venkatesh

(2013), pp. 1410-1418, KDD'13: Proceedings of the 19th ACM SIGKDD international conference on Knowledge discovery and data mining, Chicago, Ill., E1-1

conference

Pharmacological management of unipolar depression

G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz

(2013), Vol. 127, pp. 6-23, Acta psychiatrica Scandinavica, London, Eng., C1-1

journal

Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies

A Young, J Calabrese, U Gustafsson, M Berk, S McElroy, M Thase, T Suppes, W Earley

(2013), Vol. 1, pp. 1-12, International journal of bipolar disorders, London, Eng., C1-1

journal

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder

H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Möller, S Kasper, M Berk

(2013), Vol. 14, pp. 154-219, World journal of biological psychiatry, Abingdon, Eng., C1-1

journal
2012

Psychometric properties of a scale to measure investment in the sick role : the Illness Cognitions Scale

M Berk, L Berk, S Dodd, F Jacka, P Fitzgerald, A de Castella, S Filia, K Filia, J Kulkarni, H Jackson, L Stafford

(2012), Vol. 18, pp. 360-364, Journal of evaluation of clinical practice, Oxford, England, C1-1

journal

Dietary selenium intake and major depressive disorder: a nested case-control study

J Pasco, F Jacka, L Williams, M Evans-Cleverdon, S Brennan, M Kotowicz, G Nicholson, M Ball, M Berk

(2012), Vol. 20, pp. 119-123, Complementary therapies in medicine, Kidlington, England, C1

journal

Pure and comorbid depression : a comparison of symptom profile and impairment in 64.000 adults. The HUNT Study.

O Bjerkeset, L Williams, U Romild, M Berk

(2012), British journal of psychiatry, London, England, C1

journal

Nutrient intakes and the common mental disorders in women

F Jacka, M Maes, J Pasco, L Williams, M Berk

(2012), Vol. 141, pp. 79-85, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A comparison of inflammatory markers in depressed and nondepressed smokers.

S Nunes, H Vargas, J Brum, E Prado, M Vargas, M de Castro, S Dodd, M Berk

(2012), Vol. 14, pp. 540-546, Nicotine and tobacco research, Oxford , England, C1-1

journal

Co-morbid cardiovascular disease and depression : sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study

A O'Neil, E Williams, C Stevenson, B Oldenburg, M Berk, K Sanderson

(2012), Vol. 47, pp. 1145-1151, Social psychiatry and psychiatric epidemiology, Heidelberg , Germany, C1

journal

The role of alprazolam for the treatment of panic disorder in Australia

S Moylan, F Giorlando, T Nordfjaern, M Berk

(2012), Vol. 46, pp. 212-224, Australian and New Zealand Journal of Psychiatry, Melbourne, Vic., C1

journal

Increased IgA and IgM responses against gut commensals in chronic depression : further evidence for increased bacterial translocation or leaky gut

M Maes, M Kubera, J Leunis, M Berk

(2012), Vol. 141, pp. 55-62, Journal of affective disorders, Amsterdam, Netherlands, C1

journal

Complementary medicine, self-help and lifestyle interventions for Obessive Compulsive Disorder (OCD) and the OCD spectrum : a systematic review

J Sarris, D Camfield, M Berk

(2012), Vol. 138, pp. 213-221, Journal of affective disorders, Amsterdam, Netherlands, C1

journal

Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder

A Bechdolf, A Ratheesh, S Wood, T Tecic, P Conus, B Nelson, S Cotton, A Chanen, G Amminger, S Ruhrmann, F Schultze-Lutter, J Kosterkotter, P Fusar Poli, A Yung, M Berk, P McGorry

(2012), Vol. 18, pp. 358-375, Current pharmaceutical design, Bussum, The Netherlands, C1-1

journal

Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder

G Malhi, D Bargh, R McIntyre, M Gitlin, M Frye, M Bauer, M Berk

(2012), Vol. 14, pp. 1-21, Bipolar disorders supplement, Malden, Mass., C1

journal

Impact of sunlight on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, R Ardau, F Bellivier, M Berk, T Bjella, L Bossini, M Del Zompo, S Dodd, A Fagiolini, M Frye, A Gonzalex-Pinto, C Henry, F Kapczinski, S Kliwicki, B Konig, M Kunz, B Lafer, C Lopez-Jaramillo, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, R Morken, R Munoz, C O'Donovan, F Nery, A Pfennig, D Quiroz, N Rasgon, A Reif, J Rybakowski, K Sagduyu, C Simhandi, C Torrent, E Vieta, M Zetin, P Whybrow

(2012), Vol. [early view], pp. 1-10, Bipolar disorders, Malden, Mass., C1

journal

Deep brain stimulation for treatment-resistant depression : efficacy, safety and mechanisms of action

R Anderson, M Frye, O Abulseound, K Lee, J McGillivray, M Berk, S Tye

(2012), Vol. 36, pp. 1920-1933, Neuroscience and biobehavioral reviews, Oxford, England, C1

journal

Pain and the relationship with mood and anxiety disorders and psychological symptoms

L Williams, J Pasco, F Jacka, S Dodd, M Berk

(2012), Vol. 72, pp. 452-456, Journal of psychosomatic research, Philadelphia, Pa., C1

journal

Biological underpinnings of the commonalities in depression, somatization and chronic fatigue syndrome

G Anderson, M Maes, M Berk

(2012), Vol. 78, pp. 752-756, Medical hypotheses, Kidlington, England, C1

journal

The use of hormonal contraceptive agents and mood disorders in women

G Svendal, M Berk, J Pasco, F Jacka, A Lund, L Williams

(2012), Vol. 140, pp. 92-96, Journal of affective disorders, Amsterdam, Netherlands, C1

journal

Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization

G Anderson, M Maes, M Berk

(2012), Vol. 88, pp. 27-48, Advances in protein chemistry and structural biology, Maryland Heights, Miss., C1

journal

Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope and building morale

M Berk, L Berk, M Udina, S Moylan, L Stafford, K Hallam, S Goldstone, P McGorry

(2012), Vol. 46, pp. 92-99, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Can a targeted psychological intervention be effective for young people following a first manic episode? Results from an 18-month pilot study

C Macneil, M Hasty, S Cotton, M Berk, K Hallam, L Kader, P McGorry, P Conus

(2012), Vol. 6, pp. 380-388, Early intervention in psychiatry, Richmond, Vic., C1-1

journal

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder

P Magalhaes, O Dean, A Bush, D Copolov, D Weisinger, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2012), Vol. 37, pp. 132-135, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1

journal

Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder

P Magalhaes, F Kapczinski, A Nierenberg, T Deckersbach, D Weisinger, S Dodd, M Berk

(2012), Vol. 125, pp. 303-308, Acta psychiatrica scandinavica, Malden, Mass., C1

journal

Minocycline : therapeutic potential in psychiatry

O Dean, J Data-Franco, F Giorlando, M Berk

(2012), Vol. 26, pp. 391-401, CNS Drugs, Auckland, New Zealand, C1

journal

Amygdala and insula volumes prior to illness onset in bipolar disorder : a magnetic resonance imaging study

A Bechdolf, S Wood, B Nelson, D Velakoulis, M Yucel, T Takahashi, A Yung, M Berk, M Wong, C Pantelis, P McGorry

(2012), Vol. 201, pp. 34-39, Psychiatry research : neuroimaging, County Clare, Ireland, C1-1

journal

Depressive symptoms in first episode schizophrenia spectrum disorder

S Cotton, M Lambert, B Schimmelmann, A Mackinnon, J Gleeson, M Berk, L Hides, A Chanen, P McGorry, P Conus

(2012), Vol. 134, pp. 20-26, Schizophrenia research, Amsterdam, Netherlands, C1

journal

New drug targets in depression : inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors

M Maes, Z Fisar, M Medina, G Scapagnini, G Nowak, M Berk

(2012), Vol. 20, pp. 127-150, Inflammopharmacology, Basel, Switzerland, C1-1

journal

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

M Maes, M Berk, L Goehler, C Song, G Anderson, P Galecki, B Leonard

(2012), Vol. 10, pp. 1-19, BMC medicine, London, England, C1-1

journal

Maintenance N-acetyl cysteine treatment for bipolar disorder : a double-blind randomised placebo controlled trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi

(2012), Vol. 10, pp. 1-11, BMC medicine, London, England, C1

journal

Increased autoimmune activity against 5-HT : a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression

M Maes, K Ringel, M Kubera, M Berk, J Rybakowski

(2012), Vol. 136, pp. 386-392, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Cigarette smoking, nicotine dependence and anxiety disorders : a systematic review of population-based, epidemiological studies

S Moylan, F Jacka, J Pasco, M Berk

(2012), Vol. 10, pp. 1-14, BMC medicine, London, England, C1

journal

Depression, diet and exercise

F Jacka, M Berk

(2012), Vol. Open 1, pp. 21-23, Medical journal of Australia, Strawberry Hills, N.S.W., C1

journal

Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders : a review of current evidence

J Sarris, S Moylan, D Camfield, M Pase, D Mischoulon, M Berk, F Jacka, I Schweitzer

(2012), Vol. 2012, pp. 1-20, Evidence based complementary and alternative medicine, New York, N.Y., C1

journal

Using lithium as a neuroprotective agent in patients with cancer

M Khasraw, D Ashley, G Wheeler, M Berk

(2012), Vol. 10, pp. 1-7, BMC Medicine, London, England, C1

journal

Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder : a systematic review of randomized controlled clinical trials

A Ghanizadeh, M Berk

(2012), Vol. 67, pp. 122-124, European journal of clinical nutrition, London, England, C1

journal

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

A Singh, C Bousman, C Ng, K Byron, M Berk

(2012), Vol. 2, pp. 1-6, Translational psychiatry, London, England, C1

journal

Moving towards a population health approach to the primary prevention of common mental disorders

F Jacka, A Mykletun, M Berk

(2012), Vol. 10, pp. 1-6, BMC medicine, London, England, C1

journal

Co-prescription of medication for bipolar disorder and diabetes mellitus : a nationwide population based study with focus on gender differences

G Svendal, O Fasmer, A Engeland, M Berk, A Lund

(2012), Vol. 10, pp. 1-6, BMC medicine, England, London, C1

journal

Adjunctive antioxidants for bipolar disorder

P Magalhaes, O Dean, A Andreazza, M Berk, F Kapczinski

(2012), pp. 1-11, The Cochrane collaboration, Oxford, England, C1-1

journal

Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder : update 2013

L Yatham, S Kennedy, S Parikh, A Schaffer, S Beaulieu, M Alda, C O'Donovan, G MacQueen, R McIntyre, V Sharma, A Ravindran, L Young, R Milev, D Bond, B Frey, B Goldstein, B Lafer, B Birmaher, K Ha, W Nolen, M Berk

(2012), Vol. 15, pp. 1-44, Bipolar Disorders, Malden, Mass., C1

journal

State-related alterations of gene expression in bipolar disorder : a systematic review

K Munkholm, M Vinberg, M Berk, L Kessing

(2012), Vol. 14, pp. 684-696, Bipolar disorders, Malden, Mass., C1

journal

The science and practice of lithium therapy

G Malhi, M Tanious, P Das, M Berk

(2012), Vol. 46, pp. 192-211, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Treatment and outcomes of an Australian cohort of outpatients with bipolar 1 or schizoaffective disorder over twenty-four months : implications for clinical practice

J Kulkarni, S Filia, L Berk, K Filia, S Dodd, A de Castella, A Brnabic, A Lowry, K Kelin, W Montgomery, P Fitzgerald, M Berk

(2012), Vol. 12, pp. 1-11, BMC psychiatry, London, England, C1

journal

Cumulative morbidity and prognostic staging of illness in the systematic treatment enhancement program for Bipolar Disorder (STEP-BD)

P Magalhaes, S Dodd, A Nierenberg, M Berk

(2012), Vol. 46, pp. 1058-1067, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Mania : diagnosis and treatment recommendations

G Malhi, M Tanious, M Berk

(2012), Vol. 14, pp. 676-686, Current psychiatry reports, Philadelphia, Pa., C1

journal

Effects of N-acetyl cysteine on cognitive function in bipolar disorder

O Dean, A Bush, D Copolov, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2012), Vol. 66, pp. 514-517, Psychiatry and clinical neurosciences, Richmond, Vic., C1

journal

In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS) and autoimmune responses directed against O&NS- damaged neoepitopes

M Maes, M Kubera, J Leunis, M Berk, M Geffard, E Bosmans

(2012), Vol. 127, pp. 344-354, Acta psychiatrica scandinavica, Malden, Mass., C1

journal

The impact of statins on psychological wellbeing : a systematic review and meta-analysis

A O'Neil, L Sanna, C Redlich, K Sanderson, F Jacka, L Williams, J Pasco, M Berk

(2012), Vol. 10, pp. 1-9, BMC medicine, London, England, C1

journal

Pathways to new drug discovery in neuropsychiatry

M Berk

(2012), Vol. 10, pp. 1-4, BMC medicine, London, England, C1

journal
2011

Habitual physical activity and the risk for depressive and anxiety disorders among older men and women

J Pasco, L Williams, F Jacka, M Henry, C Coulson, S Brennan, E Leslie, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 23, pp. 292-298, International psychogeriatrics, Cambridge, England, C1

journal

Lower levels of physical activity in childhood associated with adult depression

F Jacka, J Pasco, L Williams, E Leslie, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 14, pp. 222-226, Journal of science and medicine in sport, Chatswood, N.S.W., C1

journal

Diet quality in bipolar disorder in a population-based sample of women

F Jacka, J Pasco, A Mykietun, L Williams, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 129, pp. 332-337, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Annual high-dose vitamin D3 and mental well-being: randomised controlled trial

K Sanders, A Stuart, E Wiliamson, F Jacka, S Dodd, G Nicholson, M Berk

(2011), Vol. 198, pp. 357-364, British journal of psychiatry, London, England, C1-1

journal

Qualitative methods in early-phase drug trials : data and methods from a trial of N-acetylcysteine in schizophrenia

M Berk, A Munib, O Dean, G Malhi, K Kohlmann, I Schapkaitz, S Jeavons, F Katz, M Anderson-Hunt, P Conus, B Hanna, R Otmar, F Ng, D Copolov, A Bush

(2011), Vol. 72, pp. 909-913, Journal of clinical psychiatry, [Memphis, Tenn.], C1-1

journal

N-acetylcysteine in psychiatry - current therapeutic evidence and potential mechanisms of action

O Dean, F Giorlando, M Berk

(2011), Vol. 36, pp. 78-86, Journal of psychiatry and neuroscience, Ottowa, Canada, C1-1

journal

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats : relevance to schizophrenia and bipolar disorder

O Dean, M van den Buuse, M Berk, D Copolov, C Mavros, A Bush

(2011), Vol. 499, pp. 149-153, Neuroscience letters, Clare, Ireland, C1-1

journal

Antioxidant treatments for schizophrenia

P Magalhaes, A Andreazza, M Berk, F Kapczinski, O Dean

(2011), pp. 1-13, Cochrane database of systematic reviews, Oxford, U. K., C1-1

journal

N-acetyl cysteine add-on treatment for bipolar II disorder : a subgroup analysis of a randomised placebo-controlled trial

P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 129, pp. 317-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder.

P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 23, pp. 87-88, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

M Berk, A Brnabic, S Dodd, K Kelin, M Tohen, G Malhi, L Berk, P Conus, P McGorry

(2011), Vol. 13, pp. 87-98, Bipolar disorders, Malden, Mass, C1

journal

Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

M Berk, F Kapczinski, A Andreazza, O Dean, F Giorlando, M Maes, M Yücel, C Gama, S Dodd, B Dean, P Magalhães, P Amminger, P McGorry, G Malhi

(2011), Vol. 35, pp. 804-817, Neuroscience & biobehavioral reviews, Oxford, England, C1-1

journal

The relationship between substance use and post-traumatic stress disorder in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2011), Vol. 52, pp. 562-566, Comprehensive psychiatry, Maryland Heights, MO, C1-1

journal

Bipolar disorder and adiposity : a study using whole body dual energy X-ray absorptiometry scans

L Williams, J Pasco, F Jacka, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 23, pp. 219-223, Acta neuropsychiatrica, Malden, Mass, C1

journal

Paracetamol (acetaminophen) use, fracture and bone mineral density

L Williams, J Pasco, M Henry, K Sanders, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 48, pp. 1277-1281, Bone, New York, N. Y., C1

journal

The association between depressive and anxiety symptoms and bone mineral density in the general population : the HUNT study

L Williams, O Bjerkeset, A Langhammer, M Berk, J Pasco, M Henry, B Schei, S Forsmo

(2011), Vol. 131, pp. 164-171, Journal of affective disorders, Amsterdam , The Netherlands, C1

journal

Area-based socioeconomic status and mood disorders : cross-sectional evidence from a cohort of randomly selected adult women

L Williams, S Brennan, M Henry, M Berk, F Jacka, G Nicholson, M Kotowicz, J Pasco

(2011), Vol. 69, pp. 173-178, Maturitas, Shannon, Ireland, C1

journal

Glutamate cysteine ligase (GCL) and self reported depression : an association study from the HUNT

M Berk, S Johansson, N Wray, L Williams, C Olsson, J Haavik, O Bjerkeset

(2011), Vol. 131, pp. 207-213, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Modeling gene-environment interaction in longitudinal data : risk for neuroticism due to interaction between maternal care and the Dopamine 4 Receptor gene (DRD4)

P Badcock, E Moore, E Williamson, M Berk, L Williams, O Bjerkeset, H Nordahl, G Patton, C Olsson

(2011), Vol. 63, pp. 18-25, Australian journal of psychology, Oxford, England, C1-1

journal

A prospective study of diet quality and mental health in adolescents

F Jacka, F Jacka, P Kremer, P Kremer, M Berk, M Berk, A de Silva-Sanigorski, A de Silva-Sanigorski, M Moodie, M Moodie, E Leslie, E Leslie, J Pasco, J Pasco, B Swinburn, B Swinburn

(2011), Vol. 6, pp. 1-7, PLos one, San Francisco, Calif., C1

journal

Don't worry, be active : positive affect and habitual physical activity

J Pasco, F Jacka, L Williams, S Brennan, E Leslie, M Berk

(2011), Vol. 45, pp. 1047-1052, Australian & New Zealand journal of psychiatry, London, England, C1

journal

The association between habitual diet quality and the common mental disorders in community-dwelling adults : The Hordaland health study

F Jacka, A Mykletun, M Berk, I Bjelland, G Tell

(2011), Vol. 73, pp. 483-490, Psychosomatic medicine, New York, N. Y., C1-1

journal

Nutraceuticals in the treatment of obsessive compulsive disorder (OCD) : a review of mechanistic and clinical evidence

D Camfield, J Sarris, M Berk

(2011), Vol. 35, pp. 887-895, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1

journal

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

Michael Berk, Olivia Dean, Sue Cotton, Clarissa Gama, Flavio Kapczinski, Brisa Fernandes, Kristy Kohlmann, Susan Jeavons, Karen Hewitt, Christine Allwang, others

(2011), Vol. 135, pp. 389-394, Journal of affective disorders, C1

journal

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

S Dodd, G Malhi, J Tiller, I Schweitzer, I Hickie, J Khoo, D Bassett, B Lyndon, P Mitchell, G Parker, P Fitzgerald, M Udina, A Singh, S Moylan, F Giorlando, C Doughty, C Davey, M Theodoros, M Berk

(2011), Vol. 45, pp. 712-725, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium

Y Wang, Z Xiao, X Liu, M Berk

(2011), Vol. 26, pp. 95-101, Human psychopharmacology : clinial and experimental, West Sussex, England, C1

journal

Development of guidelines for caregivers of people with bipolar disorder : a Delphi expert consensus study

L Berk, A Jorm, C Kelly, S Dodd, M Berk

(2011), Vol. 13, pp. 556-570, Bipolar disorders, Malden Mass., C1

journal

Meta-analytic review of neurocognition in bipolar II disorder

E Bora, M Yucel, C Pantelis, M Berk

(2011), Vol. 123, pp. 165-174, Acta psychiatrica scandinavica, Malden Mass., C1

journal

Who's left? Symptoms of schizophrenia that predict clinical trial dropout

J Thompson, M Berk, O Dean, K Kohlmann, S Jeavons, A Bush, D Copolov

(2011), Vol. 26, pp. 609-613, Human psychopharmacology, West Sussex, England, C1-1

journal

N-acetylcysteine for major depressive episodes in bipolar disorder

P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 33, pp. 374-378, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1

journal

The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.

S Moylan, J Staples, S Ward, J Rogerson, D Stein, M Berk

(2011), Vol. 31, pp. 647-652, Journal of clinical psychopharmacology, Philadelphia, Pa., C1

journal

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression : proof of concept for the inflammatory and oxidative hypotheses of depression?

L Stafford, M Berk

(2011), Vol. 72, pp. 1229-1235, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

Psychological needs of adolescents in the early phase of bipolar disorder : implications for early intervention

C Macneil, M Hasty, M Berk, L Henry, M Evans, C Redlich, R Daglas, P McGorry, P Conus

(2011), Vol. 5, pp. 100-107, Early intervention in psychiatry, Richmond, Vic., C1-1

journal

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients

M Maes, P Ruckoanich, Y Chang, N Mahanonda, M Berk

(2011), Vol. 35, pp. 769-783, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1-1

journal

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

M Maes, P Galecki, Y Chang, M Berk

(2011), Vol. 35, pp. 676-692, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1-1

journal

An examination of risk factors for readmission to acute adult mental health services within 28 days of discharge in the Australian setting

T Callaly, T Trauer, M Hyland, T Coombs, M Berk

(2011), Vol. 19, pp. 221-225, Australasian psychiatry, London, Eng., C1-1

journal
2010

Association of western and traditional diets with depression and anxiety in women

F Jacka, J Pasco, A Mykletun, L Williams, A Hodge, S O'Reilly, G Nicholson, M Katowice, M Berk

(2010), Vol. 167, pp. 305-311, American journal of psychiatry, Arlington, Va., C1-1

journal

Associations between diet quality and depressed mood in adolescents : results from the Australian healthy neighbourhoods study

F Jacka, P Kremer, E Leslie, M Berk, G Patton, J Toumbourou, J Williams

(2010), Vol. 44, pp. 435-442, Australian & New Zealand journal of psychiatry, London, England, C1

journal

Mental health services for young people - the challenge of integrating services

T Callaly, K Von Treuer, S Dodd, M Berk

(2010), Vol. 22, pp. 158-160, Acta neuropsychiatrica, Oxford, England, C1

journal

Readmission to an acute psychiatric unit within 28 days of discharge : identifying those at risk

T Callaly, M Hyland, T Trauer, S Dodd, M Berk

(2010), Vol. 34, pp. 282-285, Australian health review, Melbourne, Vic., C1

journal

A naturalistic study of treatment outcomes with aripiprazole in young people with first episode psychosis

S Dodd, T Callaly, A Thampi, S McConnell, P Hantz, D Goodman, K Kohlmann, P Vieira da Silva Magalhaes, M Berk

(2010), Vol. 8, pp. 105-110, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1

journal

Obesity is associated with previous suicide attempts in bipolar disorder

F Gomes, M Kauer-Sant'Anna, P Magalhães, F Jacka, S Dodd, C Gama, Â Cunha, M Berk, F Kaczinski

(2010), Vol. 22, pp. 63-67, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women

A Mykletun, F Jacka, L Williams, J Pasco, M Henry, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 10, pp. 1-9, BMC gastroenterology, London, England, C1-1

journal

Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression

J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 79, pp. 323-325, Psychotherapy and psychosomatics, New York, N. Y., C1-1

journal

Association of high-sensitivity C-reactive protein with de novo major depression

J Pasco, G Nicholson, L Williams, F Jacka, M Henry, M Kotowicz, H Schneider, B Leonard, M Berk

(2010), Vol. 197, pp. 372-377, British journal of psychiatry, London, England, C1-1

journal

The prevalence of mood and anxiety disorders in Australian women

L Williams, F Jacka, J Pasco, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 18, pp. 250-255, Australasian psychiatry, London, England, C1-1

journal

Termination of therapy: what can clinicians do to maximise gains?

C Macneil, M Hasty, P Conus, M Berk

(2010), Vol. 22, pp. 43-45, Acta neuropsychiatrica, Malden, Mass., C1-1

journal

Enhancing medication adherence in patients with bipolar disorder

L Berk, K Hallam, F Colom, E Vieta, M Hasty, C Macneil, M Berk

(2010), Vol. 25, pp. 1-16, Human psychopharmacology : clinical and experimental, West Sussex, England, C1-1

journal

Effects of n-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats

K Choy, O Dean, M Berk, A Bush, M van den Buuse

(2010), Vol. 649, pp. 224-228, European journal of pharmacology, Amsterdam, The Netherlands, C1-1

journal

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice

O Dean, A Bush, M Berk, D Copolov, M van den Buuse

(2010), Vol. 97, pp. 293-300, Pharmacology, biochemistry and behavior, Philadelphia, Pa., C1-1

journal

Oxidative pathways as a drug target for the treatment of autism

K Villagonzalo, S Dodd, O Dean, K Gray, B Tonge, M Berk

(2010), Vol. 14, pp. 1301-1310, Expert opinion on therapeutic targets, London, England, C1-1

journal

Restless leg syndrome caused by olanzapine: a case series

S Aggarwal, S Dodd, M Berk

(2010), Vol. 5, pp. 129-131, Current drug safety, San Francisco, Ca., C1-1

journal

From neuroprogression to neuroprotection : implications for clinical care

M Berk, P Conus, F Kapczinski, A Andreazza, M Yücel, S Wood, C Pantelis, G Malhi, S Dodd, A Bechdolf, G Amminger, I Hickie, P McGorry

(2010), Vol. 193, pp. 36-40, Medical journal of australia, Strawberry Hills, N.S.W., C1-1

journal

The validity and internal structure of the bipolar depression rating scale (BDRS): data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder

M Berk, S Dodd, O Dean, K Kohlmann, L Berk, G Malhi

(2010), Vol. 22, pp. 237-242, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Evidence and implications for early intervention in bipolar disorder

M Berk, K Hallam, G Mahli, L Henry, M Hasty, C Macneil, M Yucel, C Pantelis, B Murphy, E Vieta, S Dodd, P McGorry

(2010), Vol. 19, pp. 113-126, Journal of mental health, Abingdon, England, C1-1

journal

Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder?

M Berk, F Ng, S Dodd, J Goldberg, G Malhi

(2010), Vol. 64, pp. 367-371, Psychiatry and clinical neurosciences, Richmond, Vic., C1-1

journal

A qualitative evaluation of a regional early psychosis service 3 years after its commencement

T Callaly, C Ackerly, M Hyland, S Dodd, M O'Shea, M Berk

(2010), Vol. 34, pp. 382-385, Australian health review, Melbourne, Vic., C1-1

journal

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder

S Dodd, A Brnabic, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, K Kelin, M Smith, W Montgomery, J Kulkarni, M Berk

(2010), Vol. 51, pp. 504-509, Comprehensive psychiatry, Maryland Heights, MO, C1-1

journal

A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder

S Dodd, J Kulkarni, L Berk, F Ng, P Fitzgerald, A de Castella, S Filia, K Filia, W Montgomery, K Kelin, M Smith, A Brnabic, M Berk

(2010), Vol. 124, pp. 22-28, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia

J Kulkarni, C Gurvich, S Lee, H Gilbert, E Gavrilidis, A de Castella, M Berk, S Dodd, P Fitzgerald, S Davis

(2010), Vol. 35, pp. 1142-1147, Psychoneuroendocrinology, Oxford, England, C1-1

journal

The role of psychotherapy in bipolar disorder

S Lauder, M Berk, D Castle, S Dodd, L Berk

(2010), Vol. 193, pp. 31-35, Medical journal of australia, Sydney, N.S.W., C1-1

journal

The utility of the Mood Disorders Questionnaire as a screening tool in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2010), Vol. 14, pp. 150-153, International journal of psychiatry in clinical practice, London, England, C1-1

journal

Patterns of alcohol use and associated physical and lifestyle characteristics according to new Australian guidelines

C Coulson, L Williams, M Henry, M Berk, D Lubman, S Brennan, G Nicholson, M Kotowicz, S Korn, J Pasco

(2010), Vol. 44, pp. 946-951, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1

journal

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

A Bechdolf, B Nelson, S Cotton, A Chanen, A Thompson, J Kettle, P Conus, G Amminger, A Yung, M Berk, P McGorry

(2010), Vol. 127, pp. 316-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Group-based psychosocial intervention for bipolar disorder : randomised controlled trial

D Castle, C White, J Chamberlain, M Berk, L Berk, S Lauder, G Murray, I Schweitzer, L Piterman, M Gilbert

(2010), Vol. 196, pp. 383-388, British journal of psychiatry, London, Eng., C1-1

journal

Characterisation of the prodrome to a first episode of psychotic mania : results of a retrospective study

P Conus, J Ward, N Lucas, S Cotton, A Yung, M Berk, P McGorry

(2010), Vol. 124, pp. 341-345, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

The impact of smoking on clinical outcomes after first episode psychosis: longer-term outcome findings from the EPPIC 800 follow-up study

M Berk, L Henry, K Elkins, S Harrigan, M Harris, H Herrman, H Jackson, P McGorry

(2010), Vol. 6, pp. 212-234, Journal of dual diagnosis, Philadelphia, Pa., C1-1

journal

Pretreatment and outcome correlates of past sexual and physical trauma in 118 bipolar I disorder patients with a first episode of psychotic mania

P Conus, S Cotton, B Schimmelmann, M Berk, R Daglas, P McGorry, M Lambert

(2010), Vol. 12, pp. 244-252, Bipolar disorders, Hoboken, N.J., C1-1

journal

Pre-morbid and outcome correlates of first episode mania with psychosis: is a distinction between schizoaffective and bipolar I disorder valid in the early phase of psychotic disorders?

P Conus, A Abdel-Baki, S Harrigan, M Lambert, P McGorry, M Berk

(2010), Vol. 126, pp. 88-95, Journal of affective disorders, Amsterdam, Netherlands, C1-1

journal

Assessing oxidative pathway genes as risk factors for bipolar disorder

J Fullerton, Y Tiwari, G Agahi, A Heath, M Berk, P Mitchell, P Schofield

(2010), Vol. 12, pp. 550-556, Bipolar disorders, Hoboken, N.J., C1-1

journal

Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study

K Kelin, M Berk, M Spann, D Sagman, J Raskin, D Walker, D Perahia

(2010), Vol. 64, pp. 719-726, International journal of clinical practice, Chichester, Eng., C1-1

journal

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression

H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Möller, S Kasper, M Berk, WFSBP Task Force On Treatment Guidelines For Bipol

(2010), Vol. 11, pp. 81-109, World journal of biological psychiatry, Abingdon, Eng., C1-1

journal
2009

Description and qualitative evaluation of Jigsaw, an integrated young persons' mental health program

T Callaly, S Dodd, C Ackerly, P Hantz, M O'Shea, M Berk

(2009), Vol. 17, pp. 480-483, Australasian Psychiatry, London, England, C1-1

journal

Suicidality - the challenge for public mental health services

T Callaly, M Berk, S Dodd

(2009), Vol. 21, pp. 41-43, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Vitamin D: is it relevant to psychiatry?

M Berk, S Dodd, L Williams, F Jacka, J Pasco

(2009), Vol. 21, pp. 205-206, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Reliability of the mood disorder questionnaire : comparison with the structured clinical interview for the DSM-IV-TR in a population sample

S Dodd, L Williams, F Jacka, J Pasco, O Bjerkeset, M Berk

(2009), Vol. 43, pp. 526-530, Australian and New Zealand journal of psychiatry, Melbourne, Vic., C1-1

journal

Association between magnesium intake and depression and anxiety in community-dwelling adults : The Hordaland Health Study

F Jacka, S Overland, R Stewart, G Tell, I Bjelland, A Mykletun

(2009), Vol. 43, pp. 45-52, Australian & New Zealand journal of psychiatry, Melbourne, Vic., C1-1

journal

Depression and bone metabolism : a review

L Williams, J Pasco, F Jacka, M Henry, S Dodd, M Berk

(2009), Vol. 78, pp. 16-25, Psychotherapy and psychosomatics, New York, N. Y., C1-1

journal

Lifetime psychiatric disorders and body composition : a population-based study

L Williams, J Pasco, M Henry, F Jacka, S Dodd, G Nicholson, M Kotowicz, M Berk

(2009), Vol. 118, pp. 173-179, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting

M Berk, S Jeavons, O Dean, S Dodd, K Moss, C Gama, G Malhi

(2009), Vol. 14, pp. 357-360, CNS spectrums, New York, N.Y., C1-1

journal

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice

O Dean, A Bush, M Berk, D Copolov, M van den Buuse

(2009), Vol. 198, pp. 258-262, Behavioural brain research, Amsterdam, The Netherlands, C1-1

journal

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

O Dean, M van den Buuse, A Bush, D Copolov, F Ng, S Dodd, M Berk

(2009), Vol. 16, pp. 2965-2976, Current medicinal chemistry, Schiphol, The Netherlands, C1-1

journal

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics : a double-blind, randomised, placebo-controlled clinical trial

M Berk, C Gama, S Sundram, H Hustig, L Koopowitz, R D'Souza, H Malloy, C Rowland, A Monkhouse, A Monkhouse, F Bole, S Sathiyamoorthy, D Piskulic, S Dodd

(2009), Vol. 24, pp. 233-238, Human psychopharmacology : clinical and experimental, West Sussex, England, C1-1

journal

Early intervention in bipolar disorders : clinical, biochemical and neuroimaging imperatives

M Berk, G Malhi, K Hallam, C Gama, S Dodd, A Andreazza, B Frey, F Kapczinski

(2009), Vol. 114, pp. 1-13, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Effects of N-acetylcysteine on substance use in bipolar disorder : a randomized placebo controlled clinical trial

M Bernardo, S Dodd, C Gama, D Copolov, O Dean, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush, M Berk

(2009), Vol. 21, pp. 239-245, Acta neuropsychiatrica, Oxford, England, C1-1

journal

The impact of age at onset of bipolar I disorder on functioning and clinical presentation

F Biffin, S Tahtalian, K Filia, P Fitzgerald, A De Castella, S Filia, M Berk, S Dodd, P Callaly, L Berk, K Kelin, M Smith, W Montgomery, J Kulkarni

(2009), Vol. 21, pp. 191-196, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Client-reported reasons for non-engagement in drug and alcohol treatment

C Coulson, F Ng, M Geertsema, S Dodd, M Berk

(2009), Vol. 28, pp. 372-378, Drug and alcohol review, Oxford, England, C1-1

journal

'Mind and body' : a lifestyle programme for people on antipsychotic medication

A Jones, A Benson, S Griffiths, M Berk, S Dodd

(2009), Vol. 15, pp. 276-280, Journal of evaluation of clinical practice, Oxford, England, C1-1

journal

Improvement of negative and positive symptoms in treatment-refractory schizophrenia : a double-blind, randomized, placebo-controlled trial with memantine as add-On therapy to clozapine

D De Lucena, B Fernandes, M Berk, S Dodd, D Medeiros, M Pedrini, M Kunz, F Gomes, L Giglio, M Lobato, P Belmonte-de-Abreu, C Gama

(2009), Vol. 70, pp. 1416-1423, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

The management of individuals with bipolar disorder : a review of the evidence and its integration into clinical practice

G Malhi, D Adams, C Cahill, S Dodd, M Berk

(2009), Vol. 69, pp. 2063-2101, Drugs, London, England, C1-1

journal

Clinical practice recommendations for depression

G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder

(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, London, Eng., C1-1

journal

Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes?

L Stafford, M Berk, H Jackson

(2009), Vol. 66, pp. 211-220, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1

journal

Medial temporal lobe glutathione concentration in first episode psychosis : a 1H-MRS investigation

S Wood, G Berger, R Wellard, T Proffitt, M McConchie, M Berk, P McGorry, C Pantelis

(2009), Vol. 33, pp. 354-357, Neurobiology of disease, Amsterdam, The Netherlands, C1-1

journal

Is lithium in a class of its own? A brief profile of its clinical use

G Malhi, D Adams, M Berk

(2009), Vol. 43, pp. 1096-1104, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

journal

Medicating mood with maintenance in mind : bipolar depression pharmacotherapy

G Malhi, D Adams, M Berk

(2009), Vol. 11, pp. 55-76, Bipolar disorders, London, Eng., C1-1

journal

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

M Tohen, E Frank, C Bowden, F Colom, S Ghaemi, L Yatham, G Malhi, J Calabrese, W Nolen, E Vieta, F Kapczinski, G Goodwin, T Suppes, G Sachs, K Chengappa, H Grunze, P Mitchell, S Kanba, M Berk

(2009), Vol. 11, pp. 453-473, Bipolar disorders, London, Eng., C1-1

journal

Clinical practice recommendations for bipolar disorder

G Malhi, D Adams, L Lampe, M Paton, N O'Connor, L Newton, G Walter, A Taylor, R Porter, R Mulder, M Berk

(2009), Vol. 119, pp. 27-46, Acta psychiatrica Scandinavica, London, Eng., C1-1

journal

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

F Kapczinski, V Dias, M Kauer-Sant'Anna, E Brietzke, G Vazquez, E Vieta, M Berk

(2009), Vol. 33, pp. 1366-1371, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1-1

journal

Neuroprogression: pathways to progressive brain changes in bipolar disorder

M Berk

(2009), Vol. 12, pp. 441-445, International journal of neuropsychopharmacology, Cambridge, Eng., C1-1

journal

Clinical implications of a staging model for bipolar disorders

F Kapczinski, V Dias, M Kauer-Sant'Anna, B Frey, R Grassi-Oliveira, F Colom, M Berk

(2009), Vol. 9, pp. 957-966, Expert review of neurotherapeutics, London, Eng., C1-1

journal

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

P McGorry, B Nelson, G Amminger, A Bechdolf, S Francey, G Berger, A Riecher-Rössler, J Klosterkötter, S Ruhrmann, F Schultze-Lutter, M Nordentoft, I Hickie, P McGuire, M Berk, E Chen, M Keshavan, A Yung

(2009), Vol. 70, pp. 1206-1212, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

Cognitive-personality style as vulnerability to depression in patients with coronary artery disease: roles of sociotropy and autonomy

L Stafford, H Jackson, M Berk

(2009), Vol. 71, pp. 63-69, Psychosomatic medicine, Philadelphia, Pa., C1-1

journal

Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series

M Juruena, C Gama, M Berk, P Belmonte-de-Abreu

(2009), Vol. 23, pp. 985-987, Journal of psychopharmacology, Thousand Oaks, Calif., C1-1

journal

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

F Ng, O Mammen, I Wilting, G Sachs, I Ferrier, F Cassidy, S Beaulieu, L Yatham, M Berk

(2009), Vol. 11, pp. 559-595, Bipolar disorders, London, Eng., C1-1

journal

The elephant on the couch: side-effects of psychotherapy

M Berk, G Parker

(2009), Vol. 43, pp. 787-794, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

journal

Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder

S Boer, M Berk, B Dean

(2009), Vol. 466, pp. 27-29, Neuroscience letters, Shannon, Ireland, C1-1

journal

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis

F Benazzi, M Berk, M Frye, W Wang, A Barraco, M Tohen

(2009), Vol. 70, pp. 1424-1431, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

L Yatham, S Kennedy, A Schaffer, S Parikh, S Beaulieu, C O'Donovan, G MacQueen, R McIntyre, V Sharma, A Ravindran, L Young, A Young, M Alda, R Milev, E Vieta, J Calabrese, M Berk, K Ha, F Kapczinski

(2009), Vol. 11, pp. 225-255, Bipolar disorders, London, Eng., E1-1

conference

Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression

K Hallam, D Smith, M Berk

(2009), Vol. 112, pp. 212-218, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients

E Vieta, M Berk, W Wang, F Colom, M Tohen, R Baldessarini

(2009), Vol. 119, pp. 22-27, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

A critical update on psychological interventions for bipolar disorders

E Vieta, I Pacchiarotti, M Valentí, M Berk, J Scott, F Colom

(2009), Vol. 11, pp. 494-502, Current psychiatry reports, [Philadelphia, Pa.], C1-1

journal

Family intervention for suicide prevention: a specialized emergency department intervention for suicidal youths

J Asarnow, M Berk, L Baraff

(2009), Vol. 40, pp. 118-125, Professional psychology: research and practice, [Washington, D.C.], C1-1

journal

Clinical practice recommendations for depression

G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder

(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, Chichester, Eng., C1-1

journal
2008

A descriptive interview with 64 patients discharged from an acute-psyciatric-inpatient service

T Callaly, S Dodd, D Goodman, Y Asgari, M Berk

(2008), Vol. 14, pp. 990-995, Journal of evaluation in clinical practice, Oxford, England, C1-1

journal

Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample

M Berk, F Jacka, L Williams, F Ng, S Dodd, J Pasco

(2008), Vol. 42, pp. 874-878, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1

journal

Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet

L Guimarães, F Jacka, C Gama, M Berk, C Leitão-Azevedo, M Belmonte de Abreu, M Lobato, A Andreazza, K Ceresér, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 32, pp. 1595-1598, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1-1

journal

Brain-derived neurotrophic factor: a modifiable common mediator in both the pathophysiology of psychiatric illness and in successful pharmacological treatments

F Jacka, C Gama, M Berk

(2008), Vol. 20, pp. 223-225, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Leptin in depressed women : Cross-sectional and longitudinal data from an epidemiologic study

J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 107, pp. 221-225, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Tobacco smoking as a risk factor for major depressive disorder : a population-based study

J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 193, pp. 322-326, British journal of psychiatry, London, England, C1-1

journal

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

L Williams, M Henry, M Berk, S Dodd, F Jacka, M Kotowicz, G Nicholson, J Pasco

(2008), Vol. 23, pp. 84-87, International clinical psychopharmacology, Philadelphia, Pa., C1-1

journal

N-acetyl cysteine for depressive symptoms in bipolar disorder - a double blind, randomized, placebo-controlled trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush

(2008), Vol. 64, pp. 468-475, Biological psychiatry, Philadelphia, Pa., C1-1

journal

N-Acetyl cysteine as a glutathione precursor for schizophrenia : a double blind, randomized, placebo-controlled trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush

(2008), Vol. 64, pp. 361-368, Biological psychiatry, Philadelphia, Pa., C1-1

journal

Glutathione : a novel treatment target in psychiatry

M Berk, F Ng, O Dean, S Dodd, A Bush

(2008), Vol. 29, pp. 346-351, Trends in pharmacological sciences, London, England, C1-1

journal

Oxidative stress in psychiatric disorders : evidence base and therapeutic implications

F Ng, M Berk, O Dean, A Bush

(2008), Vol. 11, pp. 851-876, International journal of neuropsychopharmacology, Cambridge, England, C1-1

journal

N-acetylcysteine for antioxidant therapy : pharmacology and clinical utility

S Dodd, O Dean, D Copolov, G Malhi, M Berk

(2008), Vol. 8, pp. 1955-1962, Expert opinion on biological therapy, London, England, C1-1

journal

Small shifts in diurnal rhythms are associated with an increase in suicide : the effect of daylight saving

M Berk, S Dodd, K Hallam, L Berk, J Gleeson, M Henry

(2008), Vol. 6, pp. 22-25, Sleep and biological rhythms, Wiley-Blackwell Publishing Asia, C1-1

journal

The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use

M Berk, F Ng, S Dodd, T Callaly, S Campbell, M Bernardo, T Trauer

(2008), Vol. 14, pp. 979-983, Journal of evaluation of clinical practice, Oxford, England, C1-1

journal

Going up in smoke : tobacco smoking is associated with worse treatment outcomes in mania

M Berk, F Ng, W Wang, M Tohen, D Lubman, E Vieta, S Dodd

(2008), Vol. 110, pp. 126-134, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Olanzapine / fluoxetine combination for treatment resistant depression : efficacy and clinical utility

S Dodd, M Berk

(2008), Vol. 8, pp. 1299-1306, Expert review of neurotherapeutics, London, England, C1-1

journal

Duloxetine for major depression

S Dodd, M Berk

(2008), Vol. 9, pp. 65-66, Medicine today, Neutral Bay, N.S.W., C1-1

journal

The bipolar comprehensive outcomes study (BCOS) : baseline findings of an Australian cohort study

J Kulkarni, M Berk, P Fitzgerald, A de Castella, W Montgomery, K Kelin, A Brnabic, R Granger, S Dodd

(2008), Vol. 107, pp. 135-144, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Depressive disorders and bone mineral density in a community based sample of premenopausal women

L Williams, J Pasco, F Jacka, S Dodd, G Nicholson, M Berk

(2008), Vol. 107, pp. 96-97, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Illness beliefs about heart disease and adherence to secondary prevention regimens

L Stafford, H Jackson, M Berk

(2008), Vol. 70, pp. 942-948, Psychosomatic Medicine, Philadelphia, Pa., C1-1

journal

Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers?

E Bora, M Yucel, A Fornito, M Berk, C Pantelis

(2008), Vol. 118, pp. 172-187, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

journal

Decreased serum neurotrophin 3 in chronically medicated schizophrenic males

H Vargas, C Gama, A Andreazza, D Medeiros, L Stertz, G Fries, J Palha, K Cereser, M Berk, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 440, pp. 197-201, Neuroscience Letters, Shannon, Clare Ireland, C1-1

journal

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush

(2008), Vol. 64, pp. 361-368, Biological Psychiatry, Philadelphia, Pa., C1-1

journal

The empirical redefinition of the psychometric criteria for remission in bipolar disorder

M Berk, F Ng, W Wang, J Calabrese, P Mitchell, G Malhi, M Tohen

(2008), Vol. 106, pp. 153-158, Journal of Affective Disorders, Amsterdam, The Netherlands, C1-1

journal

Pure and mixed manic subtypes: a review of diagnostic classification and validation

F Cassidy, L Yatham, M Berk, P Grof

(2008), Vol. 10, pp. 131-143, Bipolar Disorders, Hoboken, N.J., C1-1

journal

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression

G Malhi, F Ng, M Berk

(2008), Vol. 42, pp. 346-349, Australian & New Zealand Journal of Psychiatry, London, Eng., C1-1

journal

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

M Kunz, C Gama, A Andreazza, M Salvador, K Ceresér, F Gomes, P Belmonte-de-Abreu, M Berk, F Kapczinski

(2008), Vol. 32, pp. 1677-1681, Progress in Neuro-Psychopharmacology & Biological Psychiatry, Philadelphia, Pa., C1-1

journal

Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

C Gama, M Berk, A Andreazza, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 30, pp. 337-340, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1

journal

Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum

B Harvey, C Joubert, J du Preez, M Berk

(2008), Vol. 33, pp. 508-517, Neurochemical Research, New York, N.Y., C1-1

journal

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

S Lavoie, M Murray, P Deppen, M Knyazeva, M Berk, O Boulat, P Bovet, A Bush, P Conus, D Copolov, E Fornari, R Meuli, A Solida, P Vianin, M Cuénod, T Buclin, K Do

(2008), Vol. 33, pp. 2187-2199, Neuropsychopharmacology, London, Eng., C1-1

journal

Tobacco smoking as a risk factor for major depressive disorder: population-based study

J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 193, pp. 322-326, British Journal of Psychiatry, London, Eng., C1-1

journal

Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males

C Gama, M Salvador, A Andreazza, M Lobato, M Berk, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 433, pp. 270-273, Neuroscience Letters, Shannon, Clare Ireland, C1-1

journal

The proximal prodrome to first episode mania--a new target for early intervention

P Conus, J Ward, K Hallam, N Lucas, C Macneil, P McGorry, M Berk

(2008), Vol. 10, pp. 555-565, Bipolar Disorders, Hoboken, N.J., C1-1

journal

A functional MRI study of Theory of Mind in euthymic bipolar disorder patients

G Malhi, J Lagopoulos, P Das, K Moss, M Berk, C Coulston

(2008), Vol. 10, pp. 943-956, Bipolar Disorders, Hoboken, N.J., C1-1

journal

The importance of the treatment alliance in bipolar disorder

L Berk, C Macneil, D Castle, M Berk

(2008), pp. 167-182, Psychotherapies for the Psychoses: Theoretical, Cultural and Clinical Integration, B1-1

chapter
2007

Effects of a walking program in the psychiatric in-patient treatment setting: a cohort study.

F Ng, S Dodd, F Jacka, E Leslie, M Berk

(2007), Vol. 18, pp. 39-42, Health promotion journal of Australia, West Perth, W.A., C1

journal

The bipolar depression rating scale (BDRS) : its development, validation and utility

M Berk, G Malhi, C Cahill, A Carman, D Hadzi-Pavlovic, M Hawkins, M Tohen, P Mitchell

(2007), Vol. 9, pp. 571-579, Bipolar disorders, Copenhagen, Denmark, C1-1

journal

Vitamin D deficiency may play a role in depression

M Berk, K Sanders, J Pasco, F Jacka, L Williams, A Hayles, S Dodd

(2007), Vol. 69, pp. 1316-1319, Medical hypotheses, Amsterdam, The Netherlands, C1-1

journal

Depression and bone mineral density in a community sample of men : Geelong Osteoporosis Study

F Jacka, J Pasco, M Henry, S Korn, L Williams, M Kotowicz, G Nicholson, M Berk

(2007), Vol. 4, pp. 292-297, Journal of men's health & gender, Amsterdam, The Netherlands, C1-1

journal

Self-reported depression and cardiovascular risk factors in a community sample of women

F Jacka, J Pasco, S McConnell, L Williams, M Kotowicz, G Nicholson, M Berk

(2007), Vol. 48, pp. 54-59, Psychosomatics, Amsterdam, The Netherlands, C1-1

journal

Food for thought

F Jacka, M Berk

(2007), Vol. 19, pp. 321-323, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Setting the stage : from prodrome to treatment resistance in bipolar disorder

M Berk, P Conus, N Lucas, K Hallam, G Malhi, S Dodd, L Yatham, A Yung, P McGorry

(2007), Vol. 9, pp. 671-678, Bipolar disorders, Copenhagen, Denmark, C1-1

journal

History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder

M Berk, S Dodd, P Callaly, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, S Tahtalian, F Biffin, K Kelin, M Smith, W Montgomery, J Kulkarni

(2007), Vol. 103, pp. 181-186, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder

M Berk, S Dodd, M Kauer-Sant'Anna, G Malhi, M Bourin, F Kapczinski, T Norman

(2007), Vol. 116, pp. 41-49, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

journal

Monitoring the safe use of Clozapine : a consensus view from Victoria, Australia

M Berk, J Fitzsimons, T Lambert, C Pantelis, J Kulkarni, D Castle, E Ryan, S Jespersen, P McGorry, G Berger, B Kuluris, T Callaly, S Dodd

(2007), Vol. 21, pp. 117-127, CNS drugs, London, England, C1-1

journal

A survey of combination antidepressant use in Australia

D Horgan, S Dodd, M Berk

(2007), Vol. 15, pp. 26-29, Australasian psychiatry, London, England, C1-1

journal

Atypical antipsychotics for bipolar disorder : overblown or blown over?

F Ng, S Dodd, M Berk

(2007), Vol. 5, pp. 53-64, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1-1

journal

The effects of physical activity in the acute treatment of bipolar disorder : a pilot study

F Ng, S Dodd, M Berk

(2007), Vol. 101, pp. 259-262, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

The benefits of physical activity in the management of bipolar disorder

F Ng, S Dodd, M Berk

(2007), Vol. 9, pp. 83-83, Bipolar disorders, Copenhagen, Denmark, C1-1

journal

The validity of the 21-item version of the depression anxiety stress scales as a routine outcome measure

F Ng, T Trauer, S Dodd, T Callaly, S Campbell, M Berk

(2007), Vol. 19, pp. 304-310, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease.

L Stafford, M Berk, H Jackson

(2007), Vol. 29, pp. 417-424, General Hospital Psychiatry, United States, C1-1

journal

The role of lamotrigine in the management of bipolar disorder.

F Ng, K Hallam, N Lucas, M Berk

(2007), Vol. 3, pp. 463-474, Neuropsychiatric Disease and Treatment, New Zealand, C1-1

journal

CNS 14-3-3zeta: changes with sex but not psychiatric diagnoses or psychotropic drug treatment.

B Dean, S Boer, A Mackinnon, M Berk

(2007), Vol. 93, pp. 51-57, Schizophrenia Research, Netherlands, C1-1

journal

Pilot of group intervention for bipolar disorder

D Castle, M Berk, L Berk, S Lauder, J Chamberlain, M Gilbert

(2007), Vol. 11, pp. 279-284, International Journal of Psychiatry in Clinical Practice, Abingdon, Eng., C1-1

journal

Should we be targeting exercise as a routine mental health intervention?

M Berk

(2007), Vol. 19, pp. 217-218, Acta Neuropsychiatrica, C1-1

journal

The potential utility of a staging model as a course specifier: a bipolar disorder perspective.

M Berk, K Hallam, P McGorry

(2007), Vol. 100, pp. 279-281, Journal of Affective Disorders, Netherlands, C1-1

journal

Neuroprotection in emerging psychotic disorders

G Berger, M Dell'Olio, P Amminger, B Cornblatt, L Phillips, A Yung, Y Yan, M Berk, P McGorry

(2007), Vol. 1, pp. 114-127, Early Intervention in Psychiatry, Richmond, Vic., C1-1

journal

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.

C Gama, A Andreazza, M Kunz, M Berk, P Belmonte-de-Abreu, F Kapczinski

(2007), Vol. 420, pp. 45-48, Neuroscience Letters, Ireland, C1-1

journal

Does dopamine dysfunction drive depression?

G Malhi, M Berk

(2007), Beyond DSM, Beyond Neurotransmitters : 2006 Conference on Melancholia, Copenhagen, Denmark, E1-1

conference

Net-effect? Online psychological interventions

S Lauder, A Chester, M Berk

(2007), Vol. 19, pp. 386-388, Acta Neuropsychiatrica, C1-1

journal

DNA damage in rats after treatment with methylphenidate.

A Andreazza, B Frey, S Valvassori, C Zanotto, K Gomes, C Comim, C Cassini, L Stertz, L Ribeiro, J Quevedo, F Kapczinski, M Berk, C Gonçalves

(2007), Vol. 31, pp. 1282-1288, Progress in Neuro-Psychopharmacology & Biological Psychiatry, England, C1-1

journal

Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer

Z Zhao, Y Xiao, P Elson, H Tan, S Plummer, M Berk, P Aung, I Lavery, J Achkar, L Li, G Casey, Y Xu

(2007), Vol. 25, pp. 2696-2701, Journal of Clinical Oncology, Alexandria, Va., C1-1

journal

Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.

L Singh, M Berk, R Oates, Z Zhao, H Tan, Y Jiang, A Zhou, K Kirmani, R Steinmetz, D Lindner, Y Xu

(2007), Vol. 99, pp. 1313-1327, Journal of the National Cancer Institute, Oxford, Eng., C1-1

journal

Does dopamine dysfunction drive depression?

G Malhi, M Berk

(2007), Vol. 115, pp. 116-124, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

journal
2006

Depression and pain : an overview

L Williams, F Jacka, J Pasco, S Dodd, M Berk

(2006), Vol. 18, pp. 79-87, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Pharmacological treatment of anxiety and depression in pregnancy and lactation

S Dodd, J Opie, M Berk

(2006), pp. 163-184, Mood and anxiety disorders in women, Cambridge, England, B1-1

chapter

Diagnosing bipolar disorder : how can we do it better?

M Berk, L Berk, S Dodd, K Moss, G Malhi

(2006), Vol. 184, pp. 459-462, Medical journal of Australia, Strawberry Hills, N. S. W., C1-1

journal

Do magnetic fields affect behaviour? A demonstration of the relationship between geomagnetic storm activity and suicide

M Berk, S Dodd, M Henry

(2006), Vol. 27, pp. 151-155, Bioelectromagnetics, New York, N.Y., C1-1

journal

It's the economy : the effect of macroeconomic variables of the rate of suicide

M Berk, S Dodd, M Henry

(2006), Vol. 36, pp. 181-189, Psychological medicine, Cambridge, England, C1-1

journal

Health-related quality of life and functioning in bipolar disorder : the impact of pharmacotherapy

M Berk, K Hallam, N Lucas, L Kader, C MacNeil, M Hasty, S Dodd, G Malhi, P Conus

(2006), Vol. 6, pp. 509-523, Expert review of pharmacoeconomics and outcomes research, London, England, C1-1

journal

The safety of medications for the treatment of bipolar disorder during pregnancy and the peurperium

S Dodd, M Berk

(2006), Vol. 1, pp. 25-33, Current drug safety, Bussum, The Netherlands, C1-1

journal

Combination pharmacotherapy in unipolar depression

F Ng, S Dodd, M Berk

(2006), Vol. 6, pp. 1049-1060, Expert review of neurotherapeutics, London, England, C1-1

journal

Seasonal influences on first-episode admission in affective and non-affective psychosis

K Hallam, M Berk, L Kader, P Conus, N Lucas, M Hasty, C Macneil, P McGorry

(2006), Vol. 18, pp. 154-161, Acta neuropsychiatrica, Cambridge, Eng., C1-1

journal

Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?

P Conus, M Berk, P McGorry

(2006), Vol. 40, pp. 199-207, Australian and New Zealand Journal of Psychiatry, Australia, C1-1

journal

Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample

P Conus, S Cotton, A Abdel-Baki, M Lambert, M Berk, P McGorry

(2006), Vol. 8, pp. 221-231, Bipolar disorders, Chichester, Eng., C1-1

journal

The orygen first episode mania study. A randomised trial of olanzapine compared to chlorpromazine

M Berk

(2006), Vol. 9, pp. S44-S44, International Journal of Neuropsychopharmacology, Chicago, IL, E1-1

conference
2005

Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study

F Jacka, J Pasco, M Henry, M Kotowicz, S Dodd, G Nicholson, M Berk

(2005), Vol. 12, pp. 88-91, Menopause, New York, N. Y., C1-1

journal

The relationship between depression and cardiovascular disease

S McConnell, F Jacka, L Williams, S Dodd, M Berk

(2005), Vol. 9, pp. 157-167, International journal of psychiatry in clinical practice, London, England, C1-1

journal

Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?

M Berk, S Dodd

(2005), Vol. 65, pp. 39-43, Medical hypotheses, Amsterdam , Netherlands, C1-1

journal

Bipolar II disorder : a review

M Berk, S Dodd

(2005), Vol. 7, pp. 11-21, Bipolar disorders, Malden, Mass, C1-1

journal

Efficacy of atypical antipsychotics in bipolar disorder

M Berk, S Dodd

(2005), Vol. 65, pp. 257-269, Drugs, Auckland, New Zealand, C1-1

journal

The management of bipolar disorder in primary care : a review of existing and emerging therapies

M Berk, S Dodd, L Berk

(2005), Vol. 59, pp. 229-239, Psychiatry and clinical neurosciences, Richmond, Vic., C1-1

journal

Diagnosis and management of patients with bipolar disorder in primary care

M Berk, S Dodd, L Berk, J Opie

(2005), Vol. 55, pp. 662-664, British journal of general practice, London, Eng., C1-1

journal

Bipolar missed states : the diagnosis and clinical salience of bipolar mixed states

M Berk, S Dodd, G Mahli

(2005), Vol. 39, pp. 215-221, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1

journal

To combine or not to combine? A literature review of antidepressant combination therapy

S Dodd, D Horgan, G Mahli, M Berk

(2005), Vol. 89, pp. 1-3, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Clinical characteristics and management of bipolar disorder in women across the life span

S Dodd, S Katsenos, J Tiller, M Berk

(2005), Vol. 1, pp. 421-428, Women's health, London, England, C1-1

journal

A review of clozapine safety

J Fitzsimons, M Berk, T Lambert, M Bourin, S Dodd

(2005), Vol. 4, pp. 731-744, Expert opinion on drug safety, London, England, C1-1

journal

Atypical mood stabilizers : a 'typical' role for atypical antipsychotics

G Malhi, M Berk, M Bourin, B Ivanovski, S Dodd, J Lagopoulos, P Mitchell

(2005), Vol. 111, pp. 29-38, Acta psychiatrica Scandinavica, Malden, Ma., C1-1

journal

Australasian commentary on CANMAT guidelines for treatment of bipolar disorder

M Berk, I Shah, C Andrade, P Joyce, L Tiebang, K-S Ha

(2005), Vol. 7, pp. 83-86, Bipolar disorders, Copenhagen, Denmark, C1-1

journal

Executive functioning and theory of mind in euthymic bipolar disorder

A Olley, G Malhi, J Bachelor, C Cahill, P Mitchell, M Berk

(2005), Vol. 7, pp. 43-52, Bipolar disorders, Copenhagen, Denmark, C1-1

journal

KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha

Y Jiang, M Berk, L Singh, H Tan, L Yin, C Powell, Y Xu

(2005), Vol. 22, pp. 369-376, Clinical & experimental metastasis, Berlin, Germany, C1-1

journal
2004

Scale matters : the need for a Bipolar Depression Rating Scale (BDRS)

M Berk, G Malhi, P Mitchell, C Cahill, A Carman, D Hadzi-Pavlovic, M Hawkins, M Tohen

(2004), Vol. 110, pp. 39-45, Acta Psychiatrica Scandinavia, Oxford, England, C1-1

journal

Dietary omega-3 fatty acids and depression in a community sample

F Jacka, J Pasco, M Henry, M Kotowicz, G Nicholson, M Berk

(2004), Vol. 7, pp. 101-106, Nutritional neuroscience, London, England, C1-1

journal

The pharmacology of bipolar disorder during pregnancy and breastfeeding

S Dodd, M Berk

(2004), Vol. 3, pp. 221-229, Expert opinion on drug safety, London, England, C1-1

journal

Predictors of antidepressant response : a selective review

S Dodd, M Berk

(2004), Vol. 8, pp. 91-100, International journal of psychiatry in clinical practice, London, England, C1-1

journal

A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use

S Jespersen, M Berk, C Van Wyk, O Dean, S Dodd, C Szabo, C Maud

(2004), Vol. 19, pp. 161-164, International clinical psychopharmacology, Philadelphia, Pa., C1-1

journal

An audit of clinical outcomes and client and referrer satisfaction with a mood and anxiety Disorders unit

R Lewis, E Musella, M Berk, S Dodd, H McKenzie, M Hyland

(2004), Vol. 10, pp. 549-552, Journal of evaluation of clinical practice, Oxford, England, C1-1

journal

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

H Grunze, S Kasper, G Goodwin, C Bowden, H-J Möller, M Berk, WFSBP Task Force on Treatment Guidelines for Bipol

(2004), Vol. 5, pp. 120-135, World journal of biological psychiatry, Abingdon, Eng., C1-1

journal
2003

Recent developments in the treatment of bipolar disorders

M Berk, S Dodd

(2003), Vol. 12, pp. 1621-1632, Expert opinion on investigational drugs, London, England, C1-1

journal

The evolution of clinical audit as a tool for quality improvement.

M Berk, T Callaly, M Hyland

(2003), Vol. 9, pp. 251-257, Journal of Evaluation in Clinical Practice, England, C1-1

journal

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.

D Wynchank, M Berk

(2003), Vol. 18, pp. 271-275, Human Psychopharmacology, England, C1-1

journal

Effects of electroconvulsive therapy on regional cerebral blood flow measured by ??m technetium HMPAO SPECT

M Vangu, J Esser, I Boyd, M Berk

(2003), Vol. 27, pp. 15-19, Progess in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1-1

journal
2002

Serological observations in patients suffering from acute manic episodes

A Wadee, R Kuschke, L Wood, M Berk, L Ichim, M Maes

(2002), Vol. 17, pp. 175-179, Human psychopharmacology, Chichester, Eng., C1-1

journal

Barriers to treatment among members of a mental health advocacy group in South Africa

S Seedat, D Stein, M Berk, Z Wilson

(2002), Vol. 37, pp. 483-487, Social psychiatry and psychiatric epidemiology, Berlin, Germany, C1-1

journal
2001

Emerging options in the treatment of bipolar disorders

M Berk, J Segal, L Janet, M Vorster

(2001), Vol. 61, pp. 1407-1414, Drugs, Berlin, Germany, C1-1

journal

Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study.

G Schutz, M Berk

(2001), Vol. 16, pp. 275-278, International Clinical Psychopharmacology, England, C1-1

journal

Platelet glutamate receptor supersensitivity in major depressive disorder.

M Berk, H Plein, D Ferreira

(2001), Vol. 24, pp. 129-132, Clinical Neuropharmacology, United States, C1-1

journal

The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression.

W Verbeeck, M Berk, J Paiker, B Jersky

(2001), Vol. 11, pp. 215-220, European Neuropsychopharmacology, Netherlands, C1-1

journal

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

M Berk, C Ichim, S Brook

(2001), Vol. 16, pp. 87-92, International Clinical Psychopharmacology, England, C1-1

journal

The platelet as a peripheral marker in psychiatric illness

H Plein, M Berk

(2001), Vol. 16, pp. 229-236, Human Psychopharmacology - Clinical and Experimental, C1-1

journal

Personality factors, stress and immunity

A Wadee, R Kuschke, S Kometz, M Berk

(2001), Vol. 17, pp. 25-40, Stress and health, Chichester, Eng., C1-1

journal
2000

Platelet supersensitivity to thrombin stimulation in depression: a possible mechanism for the association with cardiovascular mortality.

M Berk, H Plein

(2000), Vol. 23, pp. 182-185, Clinical Neuropharmacology, UNITED STATES, C1-1

journal

Serotonergic targets in the treatment of antidepressant induced sexual dysfunction: a pilot study of granisetron and sumatriptan

M Berk, D Stein, A Potgieter, C Maud, C Els, M Janet, E Viljoen

(2000), Vol. 15, pp. 291-295, International clinical psychopharmacology, Philadelphia, Pa., C1-1

journal

Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial.

L Ichim, M Berk, S Brook

(2000), Vol. 12, pp. 5-10, Annals of Clinical Psychiatry, United States, C1-1

journal

The specificity of platelet glutamate receptor supersensitivity in psychotic disorders.

M Berk, H Plein, B Belsham

(2000), Vol. 66, pp. 2427-2432, Life Sciences, England, C1-1

journal

Augmented platelet calcium uptake in response to serotonin stimulation in patients with major depression measured using Mn2+ influx and 45Ca2+ uptake.

H Plein, M Berk, S Eppel, N Butkow

(2000), Vol. 66, pp. 425-431, Life Sciences, ENGLAND, C1-1

journal

Changes in the platelet intracellular calcium response to serotonin in patients with major depression treated with electroconvulsive therapy: state or trait marker status.

H Plein, M Berk

(2000), Vol. 15, pp. 93-98, International Clinical Psychopharmacology, England, C1-1

journal

Pharmacotherapy of mania: a review

J Segal, S Walton, H Clark, M Berk

(2000), Vol. 4, pp. 171-193, International journal of psychiatry in clinical practice, Abingdon, Eng., C1-1

journal

Risperidone compared to haloperidol in cannabis-induced psychotic disorder: a double blind randomized controlled trial

M Berk, S Brook, F Nur

(2000), Vol. 4, pp. 139-142, International journal of psychiatry in clinical practice, Abingdon, Eng., C1-1

journal
1999

Relationship between serotonin and the temperament and character inventory

A Peirson, J Heuchert, L Thomala, M Berk, H Plein, C Cloninger

(1999), Vol. 89, pp. 29-37, Psychiatry Research, Shannon, Clare Ireland, C1-1

journal

A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial

M Berk, S Brook, A Trandafir

(1999), Vol. 14, pp. 177-180, International clinical psychopharmacology, London, Eng., C1-1

journal

Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia.

M Berk, H Plein, T Csizmadia

(1999), Vol. 14, pp. 119-122, International Clinical Psychopharmacology, ENGLAND, C1-1

journal

The platelet intracellular calcium response to serotonin and thrombin in patients with panic disorder.

H Plein, M Berk

(1999), Vol. 9, pp. 107-110, European Neuropsychopharmacology, NETHERLANDS, C1-1

journal

A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa

D Stein, M Berk, C Els, R Emsley, L Gittelson, D Wilson, R Oakes, B Hunter

(1999), Vol. 89, pp. 402-406, South African Medical Journal, Claremont, South Africa, C1-1

journal
1998

Fluoxetine treatment of acral lick dermatitis in dogs: a placebo-controlled randomized double blind trial.

D Wynchank, M Berk

(1998), Vol. 8, pp. 21-23, Depression and Anxiety, UNITED STATES, C1-1

journal

The platelet intracellular calcium response to serotonin in subsyndromal depression

M Berk, V Mitchell, H Plein

(1998), Vol. 13, pp. 107-110, International clinical psychopharmacology, London, Eng., C1-1

journal

Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone.

S Saffer, M Berk

(1998), Vol. 14, pp. 89-93, The Journal of Electroconvulsive Therapy, UNITED STATES, C1-1

journal

Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial.

J Segal, M Berk, S Brook

(1998), Vol. 21, pp. 176-180, Clinical Neuropharmacology, United States, C1-1

journal

Selective serotonin reuptake inhibitor-induced disturbances of haemostasis - Mechanisms and therapeutic implications

M Berk, B Jacobson

(1998), Vol. 10, pp. 441-446, CNS Drugs, C1-1

journal
1997

A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia.

D Mattson, M Berk, M Lucas

(1997), Vol. 158, pp. 487-494, The Journal of Genetic Psychology: Research and Theory on Human Development, United States, C1-1

journal

Acute phase proteins in major depression

M Berk, A Wadee, R Kuschke, A O'Neill-Kerr

(1997), Vol. 43, pp. 529-534, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1

journal

The augmented platelet intracellular calcium response to serotonin in anorexia nervosa but not bulimia may be due to subsyndromal depression

M Berk, K Kessa, C Szabo, N Butkow

(1997), Vol. 22, pp. 57-63, International journal of eating disorders, Chichester, Eng., C1-1

journal

An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder

M Berk, A du Plessis, M Birkett, D Richardt, Lilly Duloxetine Depression Study Group

(1997), Vol. 12, pp. 137-140, International Clinical Psychopharmacology, Philadelphia, Pa., C1-1

journal

A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania

H Clark, M Berk, S Brook

(1997), Vol. 12, pp. 325-328, Human psychopharmacology, Chichester, Eng., C1-1

journal
1996

Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controls.

M Berk, N Kirchmann, N Butkow

(1996), Vol. 19, pp. 48-51, Clinical Neuropharmacology, United States, C1-1

journal
1995

The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients

M Berk, W Bodemer, T Van Oudenhove, N Butkow

(1995), Vol. 10, pp. 189-193, Human psychopharmacology: clinical and experimental, Chichester, Eng., C1-1

journal
undefined

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases.

Gerwyn Morris, Michael Berk, André Carvalho, Michael Maes, Adam Walker, Basant Puri

(), Vol. 341, pp. 154-175, Behav Brain Res, Netherlands, C1

journal

Validation of a Portable Low-Power Deep Brain Stimulation Device Through Anxiolytic Effects in a Laboratory Rat Model.

Abbas Kouzani, Rajas Kale, Pablo Zarate-Garza, Michael Berk, Ken Walder, Susannah Tye

(), Vol. 25, pp. 1365-1374, IEEE Trans Neural Syst Rehabil Eng, United States, C1

journal

Funded Projects at Deakin

Australian Competitive Grants

Providing evidence for the primary prevention of the high-prevalence mental disorders in men: the role of diet in the aetiology of depression, anxiety, and psychological distress

Prof Felice Jacka, Prof Michael Berk, Prof Julie Pasco, A/Prof Lana Williams

NHMRC Project Grant

  • 2014: $13,687
  • 2013: $142,302
  • 2012: $144,871

Diet as a therapeutic target in depression: A randomised controlled trial

Prof Felice Jacka, Prof Michael Berk, Prof David Castle, Dr Laima Brazionis, A/Prof Catherine Itsiopoulos, Dr Adrienne O'Neil

NHMRC Project Grant

  • 2015: $9,996
  • 2014: $114,611
  • 2013: $227,006
  • 2012: $65,002

Inflammatory cytokines as risk factors for the development of both depression and osteoporosis in men

Prof Michael Berk, Prof Julie Pasco, A/Prof Lana Williams, Prof Felice Jacka, Dr Margaret Henry

NHMRC Project Grant

  • 2014: $92,771
  • 2013: $129,413
  • 2012: $158,906

The Efficacy of N-acetylcysteine as an Adjunctive Treatment in Bipolar Depression: A Double-blind, Randomised, Placebo-controlled Trial

Prof Michael Berk, Dr Olivia Dean, A/Prof Susan Cotton, Dr Seetal Dodd, Prof Gin Malhi, A/Prof Chee Ng

NHMRC Project Grant

  • 2015: $69,545
  • 2014: $169,437
  • 2013: $74,883
  • 2012: $197,858

Developing evidence for the primary prevention of depressive disorders: The role of diet and physical activity

Prof Michael Berk, Prof Julie Pasco, A/Prof Evie Leslie, Prof Colin Bell, Prof Felice Jacka

NHMRC Project Grant

  • 2012: $196,827
  • 2011: $71,971

The Efficacy of N-acetylcysteine as an adjunctive treatment in unipolar depression

Prof Michael Berk, Prof Gin Malhi, Dr Seetal Dodd, Dr Olivia Dean

NHMRC Project Grant

  • 2012: $32,725
  • 2011: $48,924

Proof of principle of the inflammatory and oxidative theory of depression: A treatment study

Prof Michael Berk, Dr Andrew Chanen, Ms Susan Harrigan, Mr Christopher Davey, Dr Sarah Hetrick, Dr Olivia Dean, Dr Seetal Dodd

NHMRC Project Grant

  • 2017: $102,975
  • 2016: $152,181
  • 2015: $110,745
  • 2014: $111,704
  • 2013: $105,227
  • 2012: $26,547

Novel therapies, risk pathways and prevention of mood disorders - Senior Principal Research Fellow (SPRF)

Prof Michael Berk

NHMRC - Research Fellowship

  • 2018: $44,413
  • 2017: $175,200
  • 2016: $172,781
  • 2015: $170,395
  • 2014: $167,382

Diet and nutritional status of people with major depression

Prof Felice Jacka, Dr Ewa Szymlek-Gay, Prof Michael Berk

MLA Grant - Research - Meat & Livestock Australia Limited

  • 2015: $84,485
  • 2013: $84,300

Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder

Prof Ken Walder, Prof Michael Berk, Prof Marion Leboyer, Prof Brian Dean

NHMRC Project Grant

  • 2017: $157,493
  • 2016: $207,762
  • 2015: $117,544

The efficacy of adjunctive Garcinia mangostana Linn. pericarp for bipolar depression: A 24-week double-blind, randomized, placebo-controlled trial.

Dr Olivia Dean, Prof Michael Berk, A/Prof Chee Ng, Dr Seetal Dodd, Prof Malcolm Hopwood, Dr Alyna Turner, Prof Felice Jacka

NHMRC Project Grant

  • 2018: $80,993
  • 2017: $209,758

Other Public Sector Funding

MoodSwings: an online intervention for bipolar affective disorder

Prof Michael Berk, Ms Sue Lauder, Prof David Castle, Ms Monica Gilbert, Prof L Pitterman, A/Prof B Klein, Prof David Austin, Dr G Murray, A/Prof A Chester, Dr Seetal Dodd, Ms C Holdsworth, Dr J Chamberlain, Ms L Berk

  • 2011: $14,831

Using Lithium as a neuroprotectant in patients undergoing prophylactic cranial irradiation for small cell lung cancer - A feasibility study.

Prof David Ashley, Dr Greg Wheeler, Dr Mustafa Khasraw, Prof Michael Berk, A/Prof Robert Ramsay

  • 2012: $80,000

NHMRC Equipment Grant 2011 - Barwon Psychiatric Research Centre

Prof Michael Berk

  • 2011: $10,000

Personality disorders in the community

Prof Michael Berk, Ms Shae Quirk

  • 2015: $14,549
  • 2014: $27,642

Eppendorf Refrigerated Centrifuge 5702R

Prof Michael Berk

  • 2014: $8,100

Refrigerated Centrifuge and Vortex

Prof Michael Berk, Dr Olivia Dean

  • 2015: $8,187

NHMRC Equipment Grant 2016

Prof Michael Berk, Prof Ken Walder

  • 2016: $17,691

Industry and Other Funding

Efficacy of N-Acetyl Cysteine in Autism: A double blind, placebo-controlled randomised trial

Prof Michael Berk, Dr Seetal Dodd, Dr Olivia Dean, Dr Katherine Gray, Prof Bruce Tonge

  • 2013: $143,821
  • 2012: $119,640

Assessing an Online Psychotherapy Program for Bipolar Disorder

Prof Michael Berk, Dr Emma Gliddon

  • 2017: $3,500
  • 2016: $8,500
  • 2015: $17,000
  • 2014: $17,000
  • 2013: $17,000

The efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for the treatment of Schizophrenia: A double-blind, randomized, placebo controlled trial.

Prof Michael Berk, Dr Seetal Dodd, Dr Olivia Dean, Dr Alyna Turner, A/Prof Susan Cotton, Prof John McGrath, Dr Frances Dark, A/Prof James Scott

  • 2018: $102,626
  • 2017: $363,170
  • 2016: $239,559

1/2 A Randomized Trial of Internet-Based Interventions for Bipolar Disorder

Prof Trisha Suppes, Prof Michael Berk

  • 2017: $81,508
  • 2016: $56,252

Development of MyMAPS, a novel integrative intervention for bipolar disorder

Prof Michael Berk, Mrs Lesley Berk, Ms Frances Quirk, Prof David Castle, Dr Steve Moylan, Mrs Janine Haigh, Prof Sheri Johnson, Dr Tim Denton, A/Prof Thilo Deckersbach

  • 2017: $9,090

The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial

Dr Olivia Dean, Prof Michael Berk, Miss Melanie Ashton

  • 2018: $4,250
  • 2017: $13,136
  • 2016: $3,863

Can we reduce tobacco smoking using N-acetylcysteine as a cessation treatment?

Prof Michael Berk, Dr Seetal Dodd, Dr Olivia Dean

  • 2018: $25,000
  • 2017: $25,000

MACH-3 Exploratory Depression Diagnostic Performance: An Abbreviated Investigational Device Exemption Study

Prof Michael Berk

  • 2017: $170,500

Other Funding Sources

Deakin as a participant member of Mental Health CRC

Prof Michael Berk

  • 2018: $28,204
  • 2017: $98,592

Supervisions

Principal Supervisor
2016

Emma Gliddon

Thesis entitled: Discussion Forum Engagement in an Online Intervention for Bipolar Disorder

Doctor of Philosophy (Medicine), School of Medicine

2015

Steven Moylan

Thesis entitled: Cigarette Smoking and Increased Anxiety Symptoms and Disorders

Doctor of Philosophy (Medicine), School of Medicine

2014

Jason Hugh Thompson

Thesis entitled: Attributions of responsibility for motor vehicle accidents and post-injury outcomes

Doctor of Philosophy (Medicine), School of Medicine

Associate Supervisor
2017

Joanna Frith Dipnall

Thesis entitled: The Development of a Risk Index for Depression (RID)

Doctor of Philosophy (Medicine), School of Medicine

2016

Rajas Kale

Thesis entitled: Developing Neurostimulation Techniques to Investigate Antidepressant and Mood Modulating Behaviors

Doctor of Philosophy (Engineering), School of Engineering

Kevin Elliott Bennet

Thesis entitled: Diamond-Based Electrode for Chronic Sensing in Deep Brain Stimulation

Doctor of Philosophy (Engineering), School of Engineering

2015

Shae Quirk

Thesis entitled: Personality Disorders in the community

Doctor of Philosophy (Medicine), School of Medicine